Retention of urine

R18_RETEN_URINE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R33 Hospital discharge: ICD-9 — 7882 Hospital discharge: ICD-8 — 7861 Cause of death: ICD-10 — R33 Cause of death: ICD-9 — 7882 Cause of death: ICD-8 — 7861 2 out of 7 registries used, show all original rules.	20242
4. Check minimum number of events None	20242
5. Include endpoints None	20242
6. Filter based on genotype QC (FinnGen only)	18018

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
Special: URINERETENTION
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R30-R39
Name in latin: Retentio urinae

NAME	R18_RETEN_URINE
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R33
HD_ICD_9	7882
HD_ICD_8	7861
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R33
COD_ICD_9	7882
COD_ICD_8	7861
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Retention of urine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	130594	30375	98621
Only index persons	106312	25977	80335
Unadjusted period prevalence (%)
Whole population	2.30	0.87	2.76
Only index persons	2.55	0.95	3.07
Median age at first event (years)
Whole population	71.99	69.19	72.80
Only index persons	70.90	67.12	72.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	18018	4251	13767
Unadjusted period prevalence (%)	5.18	1.51	6.31
Median age at first event (years)	69.87	61.58	72.43

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18551: Matched controls
149937

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

KDV10

NOMESCO Finland

Internal urethrotomy

7.3

321.9

523

591

U02

ICPC

Urinary frequency/urgency

2.4

321.4

2610

9518

G04BD08

ATC

solifenacin; oral

3.2

316.9

1430

3825

KED76

NOMESCO Finland

TUVP

12.2

316.5

358

242

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

315.1

1715

5114

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

314.3

3442

14244

N99.1

ICD-10 Finland

Postprocedural urethral stricture

14.3

310.6

321

184

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

310.2

6384

32982

XKD06

NOMESCO Finland

Physiologic investigation of micturition

13.3

307.7

1458

959

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

72.3

307.7

1671

205

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

11.9

307.7

569

399

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

307.7

3132

11320

J01EA01

ATC

trimethoprim; systemic

4.3

307.7

6797

17626

N35.9

ICD-10 Finland

Urethral stricture, unspecified

10.2

307.7

653

532

R35

ICD-10 Finland

Polyuria

7.0

307.7

1970

2488

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

7.1

307.7

2963

3909

C03CA01

ATC

furosemide; systemic

2.0

307.7

7964

40490

R32

ICD-10 Finland

Unspecified urinary incontinence

8.0

307.7

581

602

Z3231

NOMESCO Finland

Registered nurse

2.0

307.7

5520

26634

U08

ICPC

Urinary retention

35.1

307.7

2537

673

XJH00

NOMESCO Finland

Transanal ultrasonography

3.9

307.7

2477

5731

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

307.7

2872

10406

AA1AD

NOMESCO Finland

CT of head and brain

2.0

307.7

6597

32221

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

5094

23053

KED22

NOMESCO Finland

Transurethral resection of prostate

12.6

307.7

4764

4008

G04CA02

ATC

tamsulosin; oral

4.6

307.7

10897

35422

U13

ICPC

Bladder symptom/complaint other

7.2

307.7

1002

1180

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.9

307.7

4038

12963

WX320

NOMESCO Finland

Spinalanesthesy

2.4

307.7

5529

22709

R30.0

ICD-10 Finland

Dysuria

5.3

307.7

915

1453

TKC22

NOMESCO Finland

Catheterisation instruction

41.6

307.7

2517

564

J01CA08

ATC

pivmecillinam; oral

2.0

307.7

5161

24024

J01MA02

ATC

ciprofloxacin; systemic

3.9

307.7

11073

40965

R31

ICD-10 Finland

Unspecified haematuria

31.4

307.7

5274

1876

KED33

NOMESCO Finland

Transurethral incision of prostate

15.4

307.7

915

502

R39.1

ICD-10 Finland

Other difficulties with micturition

11.4

307.7

1414

1077

C61

ICD-10 Finland

Malignant neoplasm of prostate

2.2

307.7

3305

13217

A28

ICPC

Limited function/disability NOS

2.4

307.7

4863

19052

G04CA01

ATC

alfuzosin; oral

2.7

307.7

4355

15543

U06

ICPC

Haematuria

8.7

307.7

1029

1011

U05

ICPC

Urination problems other

8.7

307.7

2879

3101

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

307.7

3074

11365

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

52.7

307.7

232

UKC02

NOMESCO Finland

Cystoscopy

13.3

307.7

8809

9523

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

5.6

307.7

5599

10737

KDE20

NOMESCO Finland

Removal of foreign body from urethra

10.6

307.7

453

352

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

11.4

307.7

406

294

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

7.3

307.7

867

1001

L28

ICPC

Limited function/disability (L)

2.3

307.7

4579

18467

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

36.5

307.7

276

Z93.5

ICD-10 Finland

Cystostomy status

76.6

307.7

271

N02AA05

ATC

oxycodone; systemic

2.2

307.7

4588

19557

TKC20

NOMESCO Finland

Catheterisation of bladder

9.0

307.7

4086

4583

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

307.7

5441

20997

N40

ICD-10 Finland

Hyperplasia of prostate

4.3

307.7

10105

32443

U07

ICPC

Urine symptom/complaint other

5.7

307.7

3161

5239

K59.09

ICD-10 Finland

Constipation, unspecified

3.3

307.7

1975

5278

XKD03

NOMESCO Finland

Urethral pressure profilometry

7.4

307.7

598

673

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

8.1

307.7

7826

12439

U29

ICPC

Urinary symptom/complaint other

8.1

307.7

1316

1403

Z43.5

ICD-10 Finland

Attention to cystostomy

105.1

307.7

761

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

42.6

307.7

769

152

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

5.1

307.7

4412

8681

J01MA12

ATC

levofloxacin; systemic

2.7

307.7

5030

18260

N32.0

ICD-10 Finland

Bladder-neck obstruction

12.0

307.7

492

341

SPAT1167

SPAT

Insertion of urinary catheter

11.6

307.7

2189

1712

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

5.2

307.7

841

1369

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

39.9

307.7

717

151

KCD02

NOMESCO Finland

Transurethral resection of bladder

5.3

307.7

834

1315

G04CB02

ATC

dutasteride; oral

2.8

307.7

2859

9247

XKC03

NOMESCO Finland

Water cystometry

8.7

307.7

966

943

SPAT1168

SPAT

Catheterisation training

21.4

307.7

374

144

N30.9

ICD-10 Finland

Cystitis, unspecified

5.2

307.7

1972

3330

G04CB01

ATC

finasteride; oral

2.7

307.7

4332

15368

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

16.4

307.7

340

170

G04BD12

ATC

mirabegron; oral

2.5

307.7

2568

8931

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

307.7

3433

12825

R33

ICD-10 Finland

Retention of urine

10388.9

307.7

18214

776

KED52

NOMESCO Finland

Visual laser resection of prostate

8.4

307.7

764

762

TKD00

NOMESCO Finland

Dilatation of urethra

15.4

307.7

448

241

U28

ICPC

Limited function/disability (U)

12.9

307.7

614

396

A06AD11

ATC

lactulose; oral

2.4

307.7

4071

15498

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

9800

56848

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

5.5

307.7

5508

10655

TKC20, ,

SPAT

23.0

307.7

426

153

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.9

307.7

807

1380

SPAT1262

SPAT

Handing over of treatment supplies

2.4

307.7

4364

17264

N21.0

ICD-10 Finland

Calculus in bladder

8.9

307.7

471

439

N30.0

ICD-10 Finland

Acute cystitis

4.6

307.7

4614

10078

XKD00

NOMESCO Finland

Uroflowmetry

7.5

307.7

8777

16020

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

14.8

307.7

440

246

U71

ICPC

Cystitis/urinary infection other

3.4

301.6

1235

3106

U01

ICPC

Dysuria/painful urination

3.1

297.2

1370

3708

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2.2

295.7

3129

12742

N03AX16

ATC

[U] pregabalin

2.0

295.6

4319

19854

U04

ICPC

Incontinence urine

3.1

290.4

1403

3903

KC1AT

NOMESCO Finland

Puncture of urinary bladder with ultrasound guidance

53.6

289.2

197

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.8

288.4

1633

4967

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

5.0

286.9

675

1115

N02BE01

ATC

paracetamol; systemic, rectal

2.2

286.4

16091

112011

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

8.8

285.9

401

376

J01MA06

ATC

norfloxacin; oral

2.4

283.9

2378

8761

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

281.7

4594

21876

N30

ICD-10 Finland

Cystitis

3.0

274.4

1356

3819

J01DB01

ATC

cefalexin; oral

1.9

272.9

14608

98709

SPAT1254

SPAT

Administration of medicine

2.1

267.3

3215

13710

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

263.5

6566

35522

ZXD05

NOMESCO Finland

Urgent procedure

1.8

263.0

5835

30505

7882A

ICD-9 Finland

Symptoms involving urinary system, Retention of urine

+∞

261.4

272

N05AH04

ATC

quetiapine; oral

2.1

258.5

3111

13255

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.4

257.7

1013

2476

N06AX11

ATC

mirtazapine; oral

1.8

256.3

5902

31147

A04

ICPC

Weakness/tiredness general

2.1

255.0

3107

13292

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

253.9

6257

33655

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

253.1

3052

13003

SPAT1171

SPAT

Bladder puncture

99.7

252.9

159

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

252.5

4783

23773

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.0

251.3

590

972

SPAT1216

SPAT

Assessment of functional ability

2.0

250.2

3367

14926

SPAT1229

SPAT

Assessment of need for aid

2.5

249.4

1784

6093

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

7.2

244.5

402

460

116

Kela drug reimbursment

Prostate cancer

2.3

242.1

2051

7564

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

236.6

6073

32894

ZXE00

NOMESCO Finland

One hour or less

1.7

234.8

6794

38010

UKD02

NOMESCO Finland

Urethroscopy

14.1

234.1

244

142

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

233.2

3996

19169

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

228.7

3829

18216

N03AX12

ATC

[U] gabapentin; oral

2.0

226.7

2920

12700

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

226.7

3311

15050

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

225.7

2779

11888

M03BX01

ATC

baclofen; systemic

5.2

225.4

510

812

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

5.1

225.4

523

852

R50.9

ICD-10 Finland

Fever, unspecified

2.0

222.2

3079

13734

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

217.2

4606

23511

K59.0

ICD-10 Finland

Constipation

2.7

217.1

1345

4269

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

215.6

1114

3208

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

212.5

5783

31622

SPAT1263

SPAT

Sampling

1.6

212.4

7229

41898

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

211.1

5565

30159

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

209.3

4587

23599

SPAT1301

SPAT

No procedures

1.7

207.2

5774

31727

N06AX21

ATC

duloxetine; oral

2.2

206.7

1916

7319

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

59.1

205.8

138

N05BA04

ATC

oxazepam; oral

1.8

204.7

4539

23407

UJF32

NOMESCO Finland

Coloscopy

1.7

204.4

5008

26556

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

203.7

1203

3722

U99

ICPC

Urinary disease other

8.1

203.2

301

303

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

12.6

202.9

224

145

N02AX02

ATC

tramadol; systemic, rectal

1.6

202.3

7968

47708

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

21.1

198.9

173

KCV04

NOMESCO Finland

Distension of bladder with fluid

16.7

198.3

190

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.7

197.2

682

1525

TKC50

NOMESCO Finland

Training of urinary bladder

50.0

195.7

135

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

194.9

1953

7692

KH1AD

NOMESCO Finland

CT of urinary organs

3.3

194.4

811

2054

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

4.6

192.6

502

904

A02BC02

ATC

pantoprazole; systemic

1.6

191.8

12049

80189

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

189.6

3215

15252

N05CF01

ATC

zopiclone; oral

1.6

188.2

5959

33650

C07AB07

ATC

bisoprolol; oral

1.6

184.7

9755

62081

B01AB05

ATC

enoxaparin; parenteral

1.6

183.2

5731

32218

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

181.4

3194

15309

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.7

177.6

618

1387

N30.2

ICD-10 Finland

Other chronic cystitis

8.3

173.9

254

251

KCW96

NOMESCO Finland

Other operations on bladder

8.7

173.2

244

230

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

6.8

171.7

297

360

WX002

NOMESCO Finland

Sedation and analgesia

1.8

171.3

3480

17377

R06.0

ICD-10 Finland

Dyspnoea

1.6

171.2

5075

28050

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

170.5

1762

7006

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

5.1

170.5

393

636

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

169.9

738

1915

D12

ICPC

Constipation

2.9

168.0

891

2597

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

167.8

1207

4107

OAB50, ,

SPAT

2.2

167.5

1703

6727

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

4.5

167.1

443

809

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

166.0

1723

6860

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

5.4

165.9

357

542

G04BD07

ATC

tolterodine; oral

2.8

165.3

901

2665

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

164.0

1898

7875

R11

ICD-10 Finland

Nausea and vomiting

2.2

163.1

1584

6140

N05AH03

ATC

olanzapine; systemic

2.6

163.0

1077

3518

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

162.0

6428

37975

N07AB01

ATC

carbachol; systemic

8.8

160.7

224

208

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

160.6

1259

4454

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

160.4

1721

6936

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

17.3

160.4

151

N05AX08

ATC

risperidone; systemic

2.1

160.2

1813

7457

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

10.3

159.9

200

159

R60.0

ICD-10 Finland

Localized oedema

1.9

159.7

2473

11342

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

22.4

158.9

135

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

158.6

11838

80046

WX402

NOMESCO Finland

General anaesthesia

1.7

158.3

3627

18683

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

157.7

2610

12223

JN4AD

NOMESCO Finland

Body CT examination

1.9

156.9

2465

11354

R4110

NOMESCO Finland

Physiotherapy

1.6

156.2

4813

26744

U70

ICPC

Pyelonephritis/pyelitis

4.9

156.0

370

614

A29

ICPC

General symptom/complaint other

1.8

155.8

2571

12026

N03AE01

ATC

clonazepam; systemic

2.5

155.3

1068

3555

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.7

155.0

538

1205

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

154.9

2580

12102

N06AX16

ATC

venlafaxine; oral

2.0

154.5

1945

8310

SPAT1125

SPAT

Stoma care and guidance

4.0

154.3

473

968

L02AE02

ATC

leuprorelin; implant, parenteral

2.2

154.3

1394

5242

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

10.2

152.6

192

154

R5110, ,

SPAT

2.1

152.5

1695

6918

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

152.5

2016

8761

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.8

151.6

857

2583

N05AA02

ATC

levomepromazine; systemic

2.8

151.2

853

2568

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

13.2

151.2

163

101

A01

ICPC

Pain general/multiple sites

2.0

150.8

1781

7433

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

150.6

2904

14225

S97

ICPC

Chronic ulcer skin

2.2

150.5

1484

5781

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

4.6

149.3

382

677

L02BB03

ATC

bicalutamide; oral

2.7

149.2

875

2689

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

8.3

148.8

217

214

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

4.1

148.6

451

916

R34

ICD-10 Finland

Anuria and oliguria

31.7

148.1

113

R42

ICD-10 Finland

Dizziness and giddiness

1.6

147.0

4194

22813

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

17.7

146.9

137

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

146.0

3164

16009

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

145.6

3150

15930

G04BD11

ATC

fesoterodine; oral

3.5

144.6

544

1287

Z51.5

ICD-10 Finland

Palliative care

1.9

144.3

2050

9120

M48.0

ICD-10 Finland

Spinal stenosis

1.8

142.0

2477

11759

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

141.2

1367

5282

Z2221

NOMESCO Finland

Medical doctor

1.6

139.7

4408

24522

78610

ICD-8 Finland

Symptoms referable to genito-urinary system, Retention of urine

+∞

139.2

145

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.4

139.1

537

1292

J01XE01

ATC

nitrofurantoin; oral

4.7

138.7

346

600

A41.8

ICD-10 Finland

Other specified sepsis

3.4

138.4

538

1300

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

5.9

138.2

269

370

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

138.1

907

2949

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

15.9

138.0

135

SPAT1234

SPAT

Support of social functional capacity

2.3

136.1

1122

4051

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

134.8

1367

5377

ZX136

NOMESCO Finland

Intravesicalis

7.7

133.5

205

216

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

133.0

6557

40140

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

132.8

1773

7711

N03AX09

ATC

lamotrigine; oral

2.9

132.2

688

1981

B02AA02

ATC

tranexamic acid; systemic

2.0

131.6

1743

7560

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

131.3

4713

26944

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

5.5

131.2

277

413

SPAT1172

SPAT

Guidance concerning hydration

3.1

131.1

589

1558

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

130.9

2969

15164

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

130.2

916

3077

J01MA01

ATC

ofloxacin; systemic

2.0

129.7

1659

7106

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.0

129.3

1677

7218

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

128.9

2148

10036

Z71.8

ICD-10 Finland

Other specified counselling

1.5

128.6

5125

29953

N05BA01

ATC

diazepam; systemic, rectal

1.8

128.3

2232

10564

E86

ICD-10 Finland

Volume depletion

2.9

128.1

660

1890

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

127.8

1514

6310

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

127.4

1194

4548

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

127.2

2412

11709

P20

ICPC

Memory disturbance

1.7

127.2

2995

15438

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

127.1

974

3403

KGH10

NOMESCO Finland

Operation for phimosis

2.8

126.9

686

2017

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.6

126.6

197

211

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

126.3

1717

7508

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

124.2

5010

29314

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

123.8

2283

10987

G83.4

ICD-10 Finland

Cauda equina syndrome

9.9

123.4

158

130

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

123.3

4991

29216

Z3226

NOMESCO Finland

Physiotherapist

1.7

123.2

3011

15659

N02BF02

ATC

pregabalin; oral

2.2

123.1

1123

4228

C08CA01

ATC

amlodipine; oral

1.5

122.5

7336

46446

R30.1

ICD-10 Finland

Vesical tenesmus

4.0

122.2

375

768

SPAT1255

SPAT

Intravenous administration of medicine

2.1

122.0

1365

5567

N05CD07

ATC

temazepam; oral

1.7

121.9

2379

11634

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

121.9

508

1283

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

120.8

1849

8401

N06AA09

ATC

amitriptyline; systemic

2.0

120.5

1569

6755

R15

ICD-10 Finland

Faecal incontinence

3.2

120.3

505

1281

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

119.2

8043

51989

N30.8

ICD-10 Finland

Other cystitis

6.4

119.2

215

273

N45.0

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis with abscess

7.9

119.1

180

186

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

119.0

2410

11905

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

118.6

5048

29816

R30.9

ICD-10 Finland

Painful micturition, unspecified

7.7

118.6

183

194

M54.5

ICD-10 Finland

Low back pain

1.5

118.1

5378

32203

R03BB04

ATC

tiotropium bromide; inhalant

1.8

118.0

2229

10791

N18

ICPC

Paralysis/weakness

3.2

117.9

501

1281

N35.8

ICD-10 Finland

Other urethral stricture

9.3

117.8

157

137

SPAT1260

SPAT

Consultation of another employee

1.6

117.4

2966

15537

J01XX05

ATC

methenamine; oral

6.0

116.0

222

300

Z43.6

ICD-10 Finland

Attention to other artificial openings of urinary tract

39.6

114.8

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

112.4

1027

3866

SPAT1053

SPAT

Memory test

1.6

112.3

3007

15966

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

112.1

1572

6933

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

111.8

3111

16671

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

111.7

1325

5515

A10AB05

ATC

insulin aspart; parenteral

1.9

111.6

1520

6639

N39.3

ICD-10 Finland

Stress incontinence

2.4

111.5

865

3036

Y77

ICPC

Malignant neoplasm prostate

2.3

111.3

936

3403

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

32.5

110.8

S18

ICPC

Laceration/cut

1.4

110.1

8131

53158

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

109.7

979

3649

163

Kela drug reimbursment

Abiraterone and enzalutamide

3.8

109.4

359

772

N86

ICPC

Multiple sclerosis

8.4

109.2

157

152

I50.0

ICD-10 Finland

Congestive heart failure

1.8

108.8

1907

9019

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

107.8

1123

4452

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

107.7

5545

33884

R55

ICD-10 Finland

Syncope and collapse

1.7

107.6

2241

11133

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

107.1

586

1733

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

106.4

5847

36155

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

9.7

106.3

138

116

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

105.6

1533

6834

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

104.7

1205

4957

A10AE04

ATC

insulin glargine; parenteral

1.8

104.5

1914

9163

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

104.3

4933

29612

WZC30

NOMESCO Finland

Teaching

1.6

104.2

2858

15235

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

103.4

11096

77047

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

103.2

4829

28917

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

102.9

2432

12486

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

102.9

1986

9652

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.3

102.8

128

101

WX892

NOMESCO Finland

Monitored bed care

1.9

102.8

1490

6636

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

102.7

1192

4919

A46

ICD-10 Finland

Erysipelas

1.6

102.3

2930

15775

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

102.0

929

3490

G82.2

ICD-10 Finland

Paraplegia, unspecified

7.5

101.6

160

174

N05AF03

ATC

chlorprothixene; systemic

3.1

101.5

466

1248

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

101.4

1463

6505

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

101.3

3462

19405

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.9

101.2

1447

6415

B01AA03

ATC

warfarin; systemic

1.5

101.1

4254

24918

R52.2

ICD-10 Finland

Other chronic pain

2.6

101.0

629

1989

R39.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the urinary system

5.8

100.7

199

278

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

100.7

6922

44456

N06AB04

ATC

citalopram; systemic

1.6

100.6

3116

17079

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

99.8

930

3526

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

99.7

1008

3948

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

10.6

99.5

122

N03AG01

ATC

valproic acid; systemic, rectal

2.2

99.4

972

3758

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

99.0

299

605

KCJ00

NOMESCO Finland

Cystostomy

132.4

98.9

114

TKC10, ,

SPAT

132.4

98.9

114

N05AX12

ATC

aripiprazole; systemic

2.9

98.5

496

1401

N02BF01

ATC

gabapentin; oral

1.8

98.3

1617

7491

G35

ICD-10 Finland

Multiple sclerosis

4.5

97.7

256

463

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

97.5

592

1848

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

97.1

6124

38671

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

96.3

567

1742

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.9

96.3

309

654

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

95.6

1061

4304

G04BD09

ATC

trospium; oral

3.2

95.2

400

1015

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.2

94.5

850

3176

N41.0

ICD-10 Finland

Acute prostatitis

2.8

94.3

500

1453

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

92.7

495

1444

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

92.6

529

1600

E0000UV, ,

ATC

1.4

92.5

6351

40609

R51.80

ICD-10 Finland

Headache

1.7

92.3

2024

10168

U53

ICPC

Urological, Instrument/catheter/intubate/dilate

20.5

92.3

N19

ICD-10 Finland

Unspecified kidney failure

2.2

92.3

867

3297

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

92.2

2201

11306

KA3EB

NOMESCO Finland

Antegrade pyelography

6.7

92.1

160

195

JN4BD

NOMESCO Finland

Extensive body CT

1.7

91.9

1926

9559

L02BB04

ATC

enzalutamide; oral

3.5

91.6

336

781

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

91.3

2159

11060

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

90.8

2348

12303

ZX120

NOMESCO Finland

Intravenous

1.8

90.7

1589

7495

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

90.5

4484

27022

S06.0

ICD-10 Finland

Concussion

1.7

89.8

1735

8415

M79.6

ICD-10 Finland

Pain in limb

1.4

89.8

6469

41644

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

4.2

89.7

254

489

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

89.3

3457

19833

B01AB10

ATC

tinzaparin; parenteral

1.7

89.2

1767

8630

R02

ICPC

Shortness of breath/dyspnoea

1.6

89.2

2346

12338

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

88.7

420

1145

W19

ICD-10 Finland

Unspecified fall

1.7

88.7

1753

8556

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

88.4

3059

17133

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

88.2

833

3173

L17

ICPC

Foot/toe symptom/complaint

1.4

87.8

4761

29142

109

Kela drug reimbursment

Multiple sclerosis

5.6

87.5

180

262

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

87.2

2239

11703

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

87.1

6840

44604

C10AA01

ATC

simvastatin; oral

1.4

86.9

8154

54700

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.2

86.9

249

484

H02AB06

ATC

prednisolone; systemic

1.4

86.6

8022

53697

Z2446

NOMESCO Finland

Social worker

2.0

86.5

1002

4125

K92.1

ICD-10 Finland

Melaena

1.9

86.5

1165

5055

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

86.0

1792

8870

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

6.1

85.8

162

216

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

85.7

1218

5379

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

85.3

1346

6145

N81.1

ICD-10 Finland

Cystocele

2.3

85.2

697

2501

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

83.7

681

2438

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

83.2

594

2005

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

11.2

83.1

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

82.6

1450

6834

J01FF01

ATC

clindamycin; systemic

1.4

82.4

4268

25856

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

82.3

904

3649

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

82.3

697

2538

352

Kela drug reimbursment

Abiraterone and enzalutamide

3.8

82.3

267

570

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

82.2

1111

4824

SPAT1211

SPAT

Application of soft bandage

1.8

82.1

1439

6779

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.6

81.6

289

656

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

81.6

3123

17835

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

81.2

5143

32263

R13

ICD-10 Finland

Dysphagia

1.8

80.7

1249

5665

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

80.2

1009

4275

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

79.5

832

3298

ZXA05

NOMESCO Finland

Left side

1.4

79.3

4030

24299

B01AF02

ATC

apixaban; oral

1.5

79.0

2651

14714

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

78.9

3137

18040

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

4.7

78.9

195

336

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

78.8

1321

6140

A99

ICPC

Disease/condition unspecnature/site

1.7

78.4

1709

8552

UKB02

NOMESCO Finland

Retrograde ureteroscopy

4.0

78.4

242

498

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

78.4

471

1462

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

78.4

981

4149

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

78.3

1922

9917

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

78.3

1310

6085

N32.9

ICD-10 Finland

Bladder disorder, unspecified

8.1

78.3

116

117

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

78.3

493

1567

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

78.1

2367

12841

N06AB10

ATC

escitalopram; oral

1.5

78.0

2480

13600

N07AA03

ATC

distigmine; systemic

9.2

77.3

104

ZXA00

NOMESCO Finland

Right side

1.4

77.3

4298

26320

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

5.9

76.9

150

207

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

76.9

2883

16373

C09AA05

ATC

ramipril; oral

1.4

76.8

4876

30545

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

4.8

76.5

187

319

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

76.3

3528

20882

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

76.1

1249

5765

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

76.1

4254

26064

J01CA04

ATC

amoxicillin; systemic

1.4

75.4

12932

94144

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

74.0

5158

32771

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

73.5

1139

5165

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

73.4

1234

5736

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

72.8

773

3079

L02BX03

ATC

abiraterone; oral

3.6

72.7

262

602

L02BX02

ATC

degarelix; parenteral

3.0

72.7

341

925

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

72.6

1483

7286

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.4

72.6

154

231

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

72.4

5129

32648

ZXA10

NOMESCO Finland

Bilateral

1.5

72.3

2953

17043

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

72.0

1858

9693

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

71.9

440

1378

G82.1

ICD-10 Finland

Spastic paraplegia

26.1

71.8

N32.3

ICD-10 Finland

Diverticulum of bladder

10.9

71.7

T90

ICPC

Diabetes non-insulin dependent

1.4

71.5

4477

27914

OAB43, ,

SPAT

0.6

71.5

1123

15303

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

71.0

2495

13959

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.9

70.9

224

469

N17.8

ICD-10 Finland

Other acute renal failure

3.2

70.8

302

774

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

14.6

70.7

1530

FHL

Urethrocystoscopy

2.7

70.4

407

1239

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

69.8

452

1456

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

69.8

264

627

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

69.7

3440

20561

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

69.5

805

3310

C01DA14

ATC

isosorbide mononitrate; oral

1.4

69.4

3537

21264

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.7

69.3

388

1161

N28

ICPC

Limited function/disability (N)

2.8

69.2

364

1053

M05BX04

ATC

denosumab; parenteral

1.9

69.1

954

4167

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

69.1

527

1833

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

68.8

4180

25903

A02BC01

ATC

omeprazole; systemic

1.4

68.7

4457

27923

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

68.6

1610

8199

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.6

68.5

240

541

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

68.4

3446

20666

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

68.3

881

3761

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

3.4

68.3

265

640

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

67.9

447

1452

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

67.8

1624

8312

SPAT1310

SPAT

Counselling related to known health issue

1.4

67.5

4800

30499

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

67.5

645

2466

G04AA01, ,

ATC

4.9

67.4

159

263

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

67.3

1162

5440

SPAT1127

SPAT

Enema

4.0

67.0

201

405

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

67.0

1362

6679

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.4

66.8

179

330

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

66.7

1217

5791

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

66.4

1995

10775

R52.9

ICD-10 Finland

Pain, unspecified

1.7

66.3

1493

7521

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

66.2

976

4353

SPAT1252

SPAT

Overall medication plan or its review

1.7

65.6

1231

5902

S70.0

ICD-10 Finland

Contusion of hip

2.0

65.5

718

2893

K07

ICPC

Swollen ankles/oedema

1.9

65.5

880

3809

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

65.2

683

2706

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

65.0

438

1439

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

64.9

204

426

D01

ICPC

Abdominal pain/cramps general

1.6

64.5

1574

8090

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

12.5

64.3

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

64.2

678

2695

207

Kela drug reimbursment

Chronic arrhythmias

1.4

64.0

3209

19200

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

63.9

860

3724

N05AD01

ATC

haloperidol; systemic

2.1

63.8

651

2554

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

63.8

343

1005

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.3

63.5

137

209

Y06

ICPC

Prostate symptom/complaint

2.0

63.4

769

3213

N30.4

ICD-10 Finland

Irradiation cystitis

13.6

63.4

SPAT1240

SPAT

Therapeutic discussion

1.8

63.3

1124

5304

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

63.1

499

1763

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.1

63.1

118

156

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

63.1

983

4460

G04AC01, ,

ATC

2.6

63.0

385

1205

A08

ICPC

Swelling

1.8

63.0

966

4361

S01.0

ICD-10 Finland

Open wound of scalp

1.6

63.0

1490

7596

R4120

NOMESCO Finland

Occupational therapy

1.8

63.0

992

4516

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

62.8

736

3038

Z00.8

ICD-10 Finland

Other general examinations

1.7

62.8

1195

5751

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

62.7

2051

11276

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

62.7

1430

7224

ZY010

NOMESCO Finland

Hospital outpatient

2.1

62.5

636

2492

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

62.3

1188

5719

N06AX03

ATC

mianserin; oral

2.0

62.2

747

3110

N05AB03

ATC

perphenazine; systemic, rectal

2.3

62.2

525

1908

P01AB01

ATC

metronidazole; oral, rectal

1.3

62.1

5408

35344

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

61.9

695

2825

KC1YT

NOMESCO Finland

Suprapubic catheter placement under ultrasound guidance

98.7

61.9

C03DA01

ATC

spironolactone; oral

1.5

61.6

2338

13259

N81.6

ICD-10 Finland

Rectocele

2.1

61.5

625

2447

SPAT1325

SPAT

Vaccination

1.3

61.4

5472

35871

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

61.3

668

2685

R95

ICPC

Chron obstructive pulmonary disease

2.1

61.3

638

2521

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

61.3

2281

12883

D06

ICPC

Abdominal pain localized other

1.7

61.1

1186

5738

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

61.0

6276

41972

Z50.1

ICD-10 Finland

Other physical therapy

1.9

60.9

821

3557

N06DX01

ATC

memantine; oral

1.6

60.7

1564

8139

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

60.7

2351

13383

SPAT1138

SPAT

Guidance concerning bowel function

3.0

60.7

288

787

A03

ICPC

Fever

1.5

60.7

2155

12052

R52.1

ICD-10 Finland

Chronic intractable pain

4.2

60.7

174

339

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

60.6

773

3286

A10BA02

ATC

metformin; oral

1.3

60.4

5261

34351

N48.1

ICD-10 Finland

Balanoposthitis

2.2

60.3

565

2144

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

60.2

650

2604

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

60.2

683

2787

N32.89

ICD-10 Finland

Other specified disorders of bladder

9.0

60.2

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.8

60.1

312

897

N04AA02

ATC

biperiden; systemic

2.8

59.9

316

916

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

59.8

809

3508

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

59.7

2047

11360

A02BC05

ATC

esomeprazole; systemic

1.3

59.4

6024

40173

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

59.2

2392

13724

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

59.0

819

3581

Y85

ICPC

Benign prostatic hypertrophy

2.3

58.8

462

1628

KED10

NOMESCO Finland

Retropubic prostatectomy

8.4

58.7

KDH70

NOMESCO Finland

Plastic repair of stricture of urethra

23.4

58.4

K59.01

ICD-10 Finland

Constipation outlet obstruction type

4.1

58.4

172

342

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

58.3

455

1598

B01AC04

ATC

clopidogrel; oral

1.4

58.3

3357

20534

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

58.2

396

1307

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

57.7

468

1672

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

57.7

5953

39749

P29

ICPC

Psychological sympt/compl other

1.9

57.7

780

3382

E87.6

ICD-10 Finland

Hypokalaemia

2.1

57.3

582

2278

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

57.3

586

2300

K08.3

ICD-10 Finland

Retained dental root

1.6

57.3

1352

6883

KCC10

NOMESCO Finland

Cystoprostatectomy

4.9

57.1

136

227

A10AC01

ATC

insulin (human); parenteral

1.6

57.1

1347

6856

B03XA02

ATC

darbepoetin alfa; parenteral

2.4

57.1

417

1422

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

56.9

586

2307

N39.8

ICD-10 Finland

Other specified disorders of urinary system

4.5

56.8

148

267

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

56.6

3865

24288

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

56.4

511

1912

J01CF05

ATC

flucloxacillin; systemic

1.7

56.2

1065

5116

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

56.0

512

1923

L03

ICPC

Low back symptom/complaint

1.4

55.9

3884

24468

A06AH03

ATC

naloxegol; oral

2.9

55.2

283

808

A10BH05

ATC

linagliptin; oral

1.7

55.1

1011

4812

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

55.0

424

1482

I50

ICD-10 Finland

Heart failure

2.0

55.0

661

2753

N17

ICPC

Vertigo/dizziness

1.5

54.9

1918

10677

S37.3

ICD-10 Finland

Injury of urethra

16.9

54.6

A07AA09

ATC

vancomycin; oral

2.9

54.5

277

787

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

5.7

54.3

109

155

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

54.2

676

2851

R07.3

ICD-10 Finland

Other chest pain

1.6

54.1

1557

8307

SPAT1153

SPAT

Removal of sutures

1.3

54.1

5004

32846

N06AX26

ATC

vortioxetine; oral

1.8

53.9

874

4011

U76

ICPC

Malignant neoplasm of bladder

7.7

53.9

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

53.8

819

3688

A97

ICPC

No disease

1.4

53.7

3023

18391

SPAT1360

SPAT

Extensive global examination

1.7

53.3

1108

5455

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

53.3

458

1677

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

53.2

743

3254

G04BX08, ,

ATC

3.5

53.2

195

454

G82.5

ICD-10 Finland

Tetraplegia, unspecified

10.1

53.1

N41.1

ICD-10 Finland

Chronic prostatitis

2.2

53.0

488

1839

A10BH01

ATC

sitagliptin; oral

1.5

52.7

1697

9279

A10BB12

ATC

glimepiride; oral

1.6

52.7

1396

7305

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

52.7

1374

7163

L29

ICPC

Musculoskeletal sympt/complt other

1.6

52.5

1269

6494

SPAT1312

SPAT

General health counselling

1.3

52.3

4495

29175

205

Kela drug reimbursment

Chronic hypertension

1.3

52.1

5269

34968

N05AN01

ATC

lithium; oral

2.6

52.0

328

1044

KH1EE

NOMESCO Finland

Urologic ultrasound examination

6.9

51.9

102

G82.4

ICD-10 Finland

Spastic tetraplegia

19.0

51.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

51.8

6246

42415

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

51.7

646

2727

N03AF01

ATC

carbamazepine; oral, rectal

1.8

51.6

812

3693

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.6

51.5

319

1006

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

51.2

1478

7889

N05AH02

ATC

clozapine; systemic

3.1

51.1

232

618

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.7

51.0

289

871

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

50.6

728

3219

N06AB06

ATC

sertraline; oral

1.6

50.5

1316

6856

N06AB03

ATC

fluoxetine; oral

1.5

50.3

1520

8193

J01MA14

ATC

moxifloxacin; systemic

1.6

50.2

1442

7685

R03AC02

ATC

salbutamol; inhalant

1.3

50.0

7906

55427

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

2.4

50.0

374

1290

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

49.9

457

1718

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

49.8

2509

14955

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

49.7

327

1062

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

49.6

764

3452

C09AA02

ATC

enalapril; systemic

1.3

49.6

3599

22762

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

49.5

461

1745

A06AC51

ATC

ispaghula, combinations; oral

1.9

49.4

673

2923

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

4.8

49.4

119

201

Z00.0

ICD-10 Finland

General medical examination

1.4

49.4

2916

17854

N99

ICPC

Neurological disease other

3.0

49.3

236

649

S29

ICPC

Skin symptom/complaint other

1.4

48.7

3060

18917

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.4

48.7

365

1260

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

48.7

438

1635

L03AX13

ATC

glatiramer acetate; parenteral

7.9

48.6

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

13.8

48.6

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

48.6

407

1475

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

48.4

568

2346

N04BC05

ATC

pramipexole; oral

1.6

48.3

1114

5632

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

48.2

329

1088

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

48.0

591

2482

K90

ICPC

Stroke/cerebrovascular accident

2.0

48.0

575

2392

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.2

47.8

440

1657

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

47.6

1046

5223

KH1DD

NOMESCO Finland

CT urography of urinary organs

6.6

47.6

102

TKC22, ,

SPAT

30.0

47.5

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

47.5

1302

6862

P18

ICPC

Medication abuse

4.5

47.5

123

221

U72

ICPC

Urethritis

2.7

47.1

272

828

G04BX04, ,

ATC

2.4

47.1

340

1154

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

46.9

649

2834

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.8

46.9

244

703

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.8

46.8

153

329

WVA20

NOMESCO Finland

Medicine administration

2.1

46.7

474

1855

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

46.7

911

4408

V03AE01

ATC

polystyrene sulfonate; oral

2.6

46.6

275

847

N05BE01

ATC

buspirone; oral

2.2

46.4

420

1571

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

46.4

489

1941

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

46.4

625

2705

E000001, ,

ATC

1.4

46.4

2700

16475

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.7

46.2

255

758

F03

ICD-10 Finland

Unspecified dementia

1.7

46.2

923

4494

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

46.2

565

2367

J01DA01

ATC

[U] cefalexin

1.3

46.0

9548

68808

ZY000

NOMESCO Finland

Hospital inpatient

3.4

46.0

172

406

P99

ICPC

Psychological disorders other

2.4

46.0

341

1172

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

45.9

1141

5874

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

45.6

1101

5628

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

45.6

1232

6470

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

45.6

840

4000

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

45.5

218

600

U14

ICPC

Kidney symptom/complaint

2.5

45.4

296

958

XF404

NOMESCO Finland

Ambulatory ECG

1.5

45.3

1385

7480

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

45.3

496

1998

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

45.1

1562

8660

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

45.0

330

1128

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

44.9

880

4261

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.6

44.8

278

878

G72.8

ICD-10 Finland

Other specified myopathies

2.4

44.6

334

1153

SPAT1104

SPAT

Monitoring of emergency patient

1.6

44.6

1031

5214

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

10.1

44.5

SPAT1285

SPAT

Provision of consultation response

1.7

44.5

804

3808

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.2

44.4

379

1384

TJF80

NOMESCO Finland

Ostomy education

3.0

44.4

212

582

XKX00

NOMESCO Finland

Pelvic floor electromyography

7.6

44.4

X58

ICD-10 Finland

Exposure to other specified factors

1.4

44.4

1998

11655

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.5

44.3

161

373

KCW96, ,

SPAT

22.0

44.3

N03AF02

ATC

oxcarbazepine; oral

2.0

44.2

488

1972

WF049

NOMESCO Finland

Radiotherapy of metastasis

1.8

44.1

653

2913

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

14.6

44.1

N05AA01

ATC

chlorpromazine; systemic, rectal

3.0

44.1

210

576

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.2

44.0

125

242

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.8

44.0

231

669

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.2

43.8

123

236

KCB00

NOMESCO Finland

Biopsy of bladder

6.2

43.8

106

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.0

43.6

499

2042

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

43.5

233

682

1523, ,

Kela drug reimbursment

3.2

43.5

182

462

TAB00

NOMESCO Finland

Lumbar puncture

1.9

43.4

580

2503

SPAT1251

SPAT

Organisation of medication

1.9

43.4

592

2573

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.6

43.3

154

352

D17

ICPC

Incontinence of bowel

3.1

43.1

196

523

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.8

43.1

119

3054, ,

Kela drug reimbursment

3.2

43.0

181

461

A10AE05

ATC

insulin detemir; parenteral

1.7

43.0

846

4101

ABD40

NOMESCO Finland

Implantation of spinal injection device

25.8

43.0

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

43.0

1693

9629

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

42.9

530

2228

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

2.2

42.9

383

1426

C07AB02

ATC

metoprolol; systemic

1.3

42.8

3662

23643

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

42.7

299

1001

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

7.7

42.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

42.7

686

3139

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

42.6

311

1061

N45

ICD-10 Finland

Orchitis and epididymitis

4.3

42.6

118

224

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.3

42.6

170

419

R82.7

ICD-10 Finland

Abnormal findings on microbiological examination of urine

6.9

42.5

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

42.4

1074

5553

N05BA12

ATC

alprazolam; oral

1.5

42.3

1261

6768

AA400

NOMESCO Finland

Electroconvulsive therapy

4.2

42.3

121

236

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

42.2

789

3771

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

42.2

1833

10618

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

42.1

1168

6170

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

42.0

1428

7882

TK800

NOMESCO Finland

Hemodialysis

2.2

42.0

376

1401

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

42.0

4335

28686

-53

ICPC

Instrument/catheter/intubate/dilate

11.3

41.9

ZXD35

NOMESCO Finland

Usual procedure

1.9

41.9

518

2179

KK1XE

NOMESCO Finland

Other ultrasound examination of retroperitoneal space and genito-urinary tract

10.9

41.9

H26.4

ICD-10 Finland

After-cataract

1.5

41.8

1692

9673

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

41.7

1445

8010

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

41.7

803

3871

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

41.6

920

4598

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

41.6

209

591

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.5

41.4

149

343

P76

ICPC

Depressive disorder

1.8

41.4

649

2947

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

41.4

592

2613

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

41.3

1424

7885

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.4

41.3

307

1057

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

9.8

41.2

N06AA10

ATC

nortriptyline; systemic

2.5

41.2

269

872

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

41.1

314

1094

AN1

Coronary angiography

1.4

41.1

2151

12876

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

41.0

332

1186

A98

ICPC

Health maint/preventive medicine

1.3

40.9

15770

121310

N20.1

ICD-10 Finland

Calculus of ureter

1.8

40.9

635

2876

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

40.8

180

472

WX882

NOMESCO Finland

High dependency care

2.0

40.8

482

1996

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

40.8

300

1028

N20.0

ICD-10 Finland

Calculus of kidney

2.2

40.7

348

1273

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

9.3

40.7

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

5.8

40.6

112

R10.0

ICD-10 Finland

Acute abdomen

2.0

40.4

484

2013

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.5

40.4

1248

6751

N07BC02

ATC

methadone; systemic

5.3

40.4

133

G20

ICD-10 Finland

Parkinson disease

1.8

40.3

637

2900

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

40.3

657

3019

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

40.3

2662

16538

SPAT1139

SPAT

Nutrition survey

1.9

40.2

514

2186

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

40.1

301

1040

H81

ICPC

Excessive ear wax

1.3

40.1

3032

19213

UJH02

NOMESCO Finland

Anoscopy

1.9

40.0

550

2396

A04AA01

ATC

ondansetron; systemic, rectal

1.6

40.0

1137

6036

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

39.9

292

998

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

39.9

2613

16209

KED00

NOMESCO Finland

Transvesical prostatectomy

11.2

39.9

N87

ICPC

Parkinsonism

2.3

39.9

316

1119

N06AA12

ATC

doxepin; systemic

1.7

39.9

749

3585

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

39.9

1159

6185

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

39.8

357

1331

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

39.8

773

3733

L86

ICPC

Back syndrome with radiating pain

1.7

39.8

836

4124

N05CF02

ATC

zolpidem; oral

1.4

39.7

2109

12650

R4110, ,

SPAT

1.4

39.7

1839

10772

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

39.6

549

2398

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

39.5

830

4094

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

39.5

597

2681

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

39.5

337

1232

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.7

39.4

220

659

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

39.4

419

1670

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

39.4

858

4272

S22.3

ICD-10 Finland

Fracture of rib

1.5

39.4

1183

6359

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

39.3

907

4582

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.9

39.3

198

561

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

39.2

1845

10838

T83.1

ICD-10 Finland

Mechanical complication of other urinary devices and implants

13.8

39.1

KCC00

NOMESCO Finland

Cystectomy

16.2

39.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

39.1

411

1631

H02AB07

ATC

prednisone; oral

1.4

39.1

2002

11932

D21

ICPC

Swallowing problem

2.4

39.1

280

948

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

39.1

157

389

R06.4

ICD-10 Finland

Hyperventilation

2.8

38.7

204

593

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

38.6

478

2011

WYA20

NOMESCO Finland

Home visit

2.2

38.6

355

1338

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

38.5

1237

6746

A11CC03

ATC

alfacalcidol; systemic

2.1

38.4

403

1598

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

38.4

5398

36997

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

38.4

701

3328

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

38.4

274

926

EBA00

NOMESCO Finland

Extraction of tooth

1.3

38.3

5222

35663

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

2.9

38.3

190

534

WW500

NOMESCO Finland

Blood transfusion

1.8

38.3

646

2999

N29

ICPC

Neurological sympt/complt other

2.3

38.2

311

1114

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

38.2

182

500

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

38.1

1126

6028

KDV20

NOMESCO Finland

Submucous urethral injection

9.0

38.1

M54.3

ICD-10 Finland

Sciatica

1.7

38.1

797

3926

KA1FN

NOMESCO Finland

Isotope renography

3.7

38.1

129

285

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

38.1

705

3361

A06AX04

ATC

linaclotide; oral

6.1

38.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

38.0

567

2536

P72

ICPC

Schizophrenia

2.5

38.0

243

780

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

38.0

605

2761

C07AA05

ATC

propranolol; systemic

1.4

37.8

2327

14285

SPAT1161

SPAT

Ultrasound examination of urinary bladder

3.9

37.8

118

246

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

37.7

5632

38846

N18.0

ICD-10 Finland

End-stage renal disease

2.7

37.6

214

648

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

37.5

1256

6907

R5130, ,

SPAT

4.4

37.5

181

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

4.6

37.5

168

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

5.5

37.3

113

R63.1

ICD-10 Finland

Polydipsia

6.6

37.2

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1.8

37.2

576

2605

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

37.2

323

1189

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

37.2

375

1465

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

37.2

227

712

WVA20, ,

SPAT

1.8

37.2

541

2401

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.9

37.1

463

1953

P03

ICPC

Feeling depressed

1.6

37.1

923

4749

NHQ40

NOMESCO Finland

Amputation of toe

2.1

37.1

353

1349

S28

ICPC

Limited function/disability (S)

3.2

37.0

152

382

K56.7

ICD-10 Finland

Ileus, unspecified

2.2

37.0

322

1187

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

36.9

1144

6189

D11

ICPC

Diarrhoea

1.5

36.8

1362

7642

WX704

NOMESCO Finland

Intubation

1.5

36.8

1161

6304

JAH01

NOMESCO Finland

Laparoscopy

1.8

36.8

531

2351

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

36.7

1021

5392

J02AC01

ATC

fluconazole; systemic

1.3

36.7

4138

27606

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

36.7

2948

18821

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

5.5

36.6

112

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.7

36.6

124

274

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

36.5

4004

26619

SPAT1101

SPAT

Orthostatic test

1.7

36.5

729

3548

K62.3

ICD-10 Finland

Rectal prolapse

2.9

36.4

183

518

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

36.4

792

3943

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

36.3

492

2134

L03AB07

ATC

interferon beta-1a; parenteral

5.4

36.3

116

N35.0

ICD-10 Finland

Post-traumatic urethral stricture

8.0

36.2

N39

ICD-10 Finland

Other disorders of urinary system

3.5

36.2

131

303

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.0

36.2

434

1806

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

36.2

1897

11342

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.7

36.2

201

601

S22

ICPC

Nail symptom/complaint

1.6

36.2

988

5197

KED72

NOMESCO Finland

Transurethral microwave therapy of prostate

11.9

36.0

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.3

35.9

287

1021

J96.1

ICD-10 Finland

Chronic respiratory failure

1.9

35.8

445

1876

NF3AA

NOMESCO Finland

Femur X-ray examination

2.1

35.7

365

1434

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

4.8

35.6

146

S76

ICPC

Skin infection other

1.6

35.6

824

4166

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

35.4

283

1006

L14

ICPC

Leg/thigh symptom/complaint

1.5

35.4

1152

6295

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

35.4

435

1826

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

35.4

798

4008

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

35.2

806

4063

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

35.2

3497

22949

C08CA02

ATC

felodipine; oral

1.4

35.2

1661

9752

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.8

35.1

181

520

H13

ICPC

Plugged feeling ear

1.3

35.0

3245

21102

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

34.9

499

2202

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.0

34.9

167

460

N02

ICD-10 Finland

Recurrent and persistent haematuria

8.8

34.9

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

34.7

151

393

S21

ICPC

Skin texture symptom/complaint

1.4

34.6

2220

13706

K92.0

ICD-10 Finland

Haematemesis

1.9

34.6

446

1904

L76

ICPC

Fracture: other

1.9

34.5

443

1887

KCE00

NOMESCO Finland

Cystolithotomy

10.2

34.5

-50

ICPC

Medication/prescr/renewal

1.7

34.5

615

2901

N06DA03

ATC

rivastigmine; oral, transdermal

1.6

34.5

836

4275

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

34.4

1443

8290

Z29

ICPC

Social problem NOS

2.2

34.4

305

1133

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.5

34.3

225

731

L75

ICPC

Fracture: femur

2.4

34.3

238

795

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

34.2

522

2351

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

34.2

2696

17147

G44.2

ICD-10 Finland

Tension-type headache

1.4

34.2

1475

8518

NFQ20

NOMESCO Finland

Amputation of femur

2.6

34.2

201

619

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

34.1

306

1142

359

Kela drug reimbursment

Mirabegroni

4.4

34.1

168

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

34.1

486

2143

N81.5

ICD-10 Finland

Vaginal enterocele

2.8

34.1

174

497

A02BC03

ATC

lansoprazole; oral

1.3

34.1

4216

28396

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.5

34.0

221

715

K29

ICPC

Cardiovascular sympt/complt other

1.6

34.0

743

3702

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

34.0

647

3108

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.3

34.0

172

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

33.9

209

659

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

33.9

206

645

SPAT1097

SPAT

Recording of ECG

1.3

33.9

2282

14186

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

3.1

33.8

149

391

C10AA05

ATC

atorvastatin; oral

1.2

33.8

7317

52296

R96

ICPC

Asthma

1.5

33.7

1284

7244

Z91.5

ICD-10 Finland

Personal history of self-harm

6.6

33.7

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.2

33.6

140

355

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.0

33.6

397

1644

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

33.6

294

1087

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

33.6

1770

10587

N34.3

ICD-10 Finland

Urethral syndrome, unspecified

7.9

33.5

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

33.5

390

1607

IGV01

NOMESCO Finland

Psychiatric network contact

3.6

33.5

115

257

F34.1

ICD-10 Finland

Dysthymia

2.0

33.5

380

1552

D09

ICPC

Nausea

1.8

33.4

482

2134

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.7

33.3

583

2735

K77

ICPC

Heart failure

1.9

33.2

432

1850

Z2445

NOMESCO Finland

Psychologist

2.0

33.2

402

1680

R04.0

ICD-10 Finland

Epistaxis

1.5

33.1

1294

7335

U27

ICPC

Fear of urinary disease other

3.7

33.1

111

244

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.9

33.1

413

1744

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.7

33.0

184

551

A07AA02

ATC

nystatin; oral

1.6

32.9

808

4143

K30

ICD-10 Finland

Functional dyspepsia

1.4

32.9

1359

7783

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

7.4

32.9

ABD34

NOMESCO Finland

Installation of a spinal cord stimulating electrode

16.2

32.9

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.3

32.9

256

900

R4120, ,

SPAT

2.6

32.9

198

617

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.0

32.8

198

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

32.6

795

4069

H25.8

ICD-10 Finland

Other senile cataract

1.4

32.6

1929

11753

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

32.5

930

4941

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

32.5

576

2712

Z93.3

ICD-10 Finland

Colostomy status

2.9

32.4

158

440

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

32.4

298

1124

OAA80, ,

SPAT

0.5

32.4

285

4671

A12AA04

ATC

calcium carbonate; oral

2.3

32.4

266

958

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.1

32.3

317

1226

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

32.3

374

1538

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

32.3

1501

8782

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.3

32.3

254

898

A11

ICPC

Chest pain NOS

1.5

32.2

1257

7121

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

32.2

3263

21434

A02BA02

ATC

ranitidine; systemic

1.3

32.1

2943

19084

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

32.1

878

4618

N05AC02

ATC

thioridazine; oral

2.3

32.1

259

926

L03AB08

ATC

interferon beta-1b; parenteral

9.2

32.0

G30.8

ICD-10 Finland

Other Alzheimer disease

1.8

32.0

478

2140

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

32.0

213

698

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

32.0

138

358

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

31.8

2034

12539

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.6

31.7

188

582

C03AA03

ATC

hydrochlorothiazide; oral

1.4

31.6

1449

8456

ZXC20

NOMESCO Finland

Use of chemical agents

2.1

31.6

325

1280

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

31.6

271

994

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

7.0

31.6

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

31.5

1242

7049

-69

ICPC

Other reason for encounter NEC

1.8

31.5

535

2488

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

31.5

1616

9616

K78

ICPC

Atrial fibrillation/flutter

1.4

31.5

1450

8470

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

31.4

191

599

Y94.0

ICD-10 Finland

Accident at home

2.1

31.4

299

1144

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

31.3

2210

13822

D64.8

ICD-10 Finland

Other specified anaemias

2.0

31.3

334

1334

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

31.3

168

494

N06AA06

ATC

trimipramine; systemic

2.1

31.1

311

1212

N06AX05

ATC

trazodone; oral

2.2

31.1

287

1084

N43.3

ICD-10 Finland

Hydrocele, unspecified

1.9

31.1

414

1787

Z08

ICPC

Social welfare problem

2.6

31.1

185

574

Y96.9

ICD-10 Finland

Unspecified type of accident

2.2

31.0

283

1064

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

30.9

439

1934

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

8.7

30.9

D07AC01

ATC

betamethasone; topical

1.2

30.9

5407

37742

A27

ICPC

Fear of other disease NOS

1.6

30.8

713

3605

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

30.7

883

4696

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

30.7

380

1600

A03FA02

ATC

cisapride; oral, rectal

1.5

30.7

1063

5882

KBV10

NOMESCO Finland

Removal of stent from ureter

3.1

30.7

137

363

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

30.6

517

2401

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

30.6

736

3756

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

30.6

815

4261

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

30.6

802

4178

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

30.4

957

5191

N03AX11

ATC

topiramate; oral

2.3

30.4

234

820

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

30.3

227

786

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.1

30.2

305

1193

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.5

30.2

203

668

A91

ICPC

Abnormal result investigation NOS

1.6

30.1

754

3885

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

30.1

1057

5865

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

30.0

927

5008

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.0

30.0

350

1444

KCF02

NOMESCO Finland

Transluminal endoscopic removal of foreign body from bladder

8.1

30.0

KC1GD

NOMESCO Finland

CT cystography of bladder

9.6

29.9

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

2.0

29.9

333

1351

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

29.9

130

339

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.1

29.8

300

1172

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

2.0

29.8

356

1481

WF002

NOMESCO Finland

Radical radiotherapy

1.5

29.8

1036

5738

R81

ICPC

Pneumonia

1.7

29.7

580

2805

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

1.9

29.7

391

1681

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

29.6

830

4389

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.3

29.6

153

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.5

29.5

189

608

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.9

29.5

387

1662

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

29.5

213

725

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

29.5

427

1894

N81

ICPC

Injury nervous system other

5.1

29.4

105

B82

ICPC

Anaemia other/unspecified

1.8

29.4

482

2220

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.9

29.4

415

1826

Y02

ICPC

Pain in testis/scrotum

2.7

29.3

163

488

Z72.2

ICD-10 Finland

Drug use

4.5

29.3

134

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.0

29.3

320

1290

D07AB08

ATC

desonide; topical

1.4

29.3

1426

8409

I20.09

ICD-10 Finland

Unstable angina

1.5

29.2

1048

5841

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.8

29.1

424

1883

S20

ICPC

Corn/callosity

2.0

29.1

347

1443

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

29.1

317

1277

R19.5

ICD-10 Finland

Other faecal abnormalities

2.3

29.0

223

781

G03HA01

ATC

cyproterone; systemic

2.6

29.0

175

547

KFC10

NOMESCO Finland

Bilateral orchiectomy

3.1

29.0

128

337

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.6

29.0

649

3254

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

29.0

890

4803

U77

ICPC

Malignant neopl urinary tract other

4.8

28.9

116

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

28.9

1436

8494

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.3

28.9

219

762

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.3

28.9

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.8

28.8

150

434

C05AA08

ATC

fluocortolone; rectal, topical

1.3

28.8

1821

11199

H46

ICD-10 Finland

Optic neuritis

3.5

28.8

105

245

WYA20, ,

SPAT

2.8

28.7

149

430

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

28.7

316

1278

S06

ICPC

Rash localized

1.6

28.7

772

4046

127

Kela drug reimbursment

Transplant complication

2.4

28.6

211

725

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

28.6

414

1836

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

28.5

1394

8222

F13.09

ICD-10 Finland

Intoxication caused by sedative and hypnotic UNS

10.5

28.5

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

28.5

358

1515

SPAT1281

SPAT

Other administrative function

1.5

28.5

1058

5935

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

28.5

220

772

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

7.6

28.5

S14.0

ICD-10 Finland

Concussion and oedema of cervical spinal cord

6.0

28.4

M54.1

ICD-10 Finland

Radiculopathy

1.7

28.4

500

2351

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

28.4

168

520

P06

ICPC

Sleep disturbance

1.4

28.3

1497

8947

A01AB09

ATC

miconazole; local oral

1.5

28.3

1091

6164

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

4.8

28.3

112

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1.8

28.3

458

2102

L02AE04

ATC

triptorelin; parenteral

2.2

28.2

260

982

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.1

28.2

121

313

J01XX08

ATC

linezolid; systemic

3.0

28.2

130

351

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

28.2

766

4023

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.5

28.2

189

622

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.0

28.1

130

352

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.2

28.1

255

958

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

28.0

356

1513

OAA67, ,

SPAT

0.6

28.0

694

8573

N05BA02

ATC

chlordiazepoxide; systemic

1.9

28.0

367

1576

N20.9

ICD-10 Finland

Urinary calculus, unspecified

1.9

28.0

386

1686

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.6

27.9

123

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

27.9

313

1274

F10.24

ICD-10 Finland

Alcohol depence active use

2.3

27.9

218

769

N41.3

ICD-10 Finland

Prostatocystitis

5.0

27.9

104

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.7

27.9

553

2687

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.5

27.8

186

611

L02AE03

ATC

goserelin; implant

2.3

27.8

217

765

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.4

27.8

205

705

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

27.8

3777

25619

L12

ICPC

Hand/finger symptom/complaint

1.3

27.8

2134

13495

D18

ICPC

Change in faeces/bowel movements

1.9

27.7

366

1576

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

27.7

308

1250

KDW96

NOMESCO Finland

Other operations on urethra

4.6

27.6

124

A05

ICPC

Feeling ill

1.6

27.6

613

3066

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.6

27.6

121

R25.2

ICD-10 Finland

Cramp and spasm

2.0

27.6

332

1386

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.2

27.5

148

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

27.5

380

1660

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

27.5

2100

13267

ZXC14

NOMESCO Finland

Other special laser technic

7.9

27.4

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

4.5

27.4

125

7362

FHL

Urethral dilatation in anesthesia or operating room

11.9

27.3

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

27.3

300

1213

T19.1

ICD-10 Finland

Foreign body in bladder

11.3

27.2

C67

ICD-10 Finland

Malignant neoplasm of bladder

5.1

27.2

L04AA06

ATC

mycophenolic acid; systemic

2.2

27.2

248

933

P01

ICPC

Feeling anxious/nervous/tense

1.5

27.2

996

5571

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

6.5

27.2

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

27.2

181

594

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

27.1

842

4553

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

27.1

374

1634

204

Kela drug reimbursment

Leukemia lymphatica

2.0

27.1

308

1260

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.5

27.1

171

547

F45.0

ICD-10 Finland

Somatization disorder

4.4

27.1

133

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

6.3

27.0

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

27.0

482

2275

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

27.0

537

2612

KCH00

NOMESCO Finland

Suture of bladder

5.6

27.0

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.3

26.9

104

252

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.6

26.9

645

3289

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

26.9

1257

7356

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

26.9

615

3100

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

26.9

1477

8882

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.7

26.9

531

2578

M04AA01

ATC

allopurinol; systemic

1.3

26.9

2575

16760

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

26.8

393

1750

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

1.8

26.8

422

1921

ZX120, ,

SPAT

2.2

26.8

235

871

N05CD02

ATC

nitrazepam; oral

2.0

26.8

290

1166

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

26.8

1342

7949

G82.0

ICD-10 Finland

Flaccid paraplegia

9.1

26.7

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

26.7

722

3787

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

26.7

944

5244

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

26.6

619

3135

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

26.5

597

2997

N21.1

ICD-10 Finland

Calculus in urethra

4.7

26.5

112

R03BA05

ATC

fluticasone; inhalant

1.3

26.5

2261

14494

R60.1

ICD-10 Finland

Generalized oedema

3.1

26.4

113

292

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

5.8

26.4

J46

ICD-10 Finland

Status asthmaticus

1.9

26.4

364

1590

LEG12

NOMESCO Finland

Transobturatoric tape

3.2

26.4

111

284

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

26.2

2715

17833

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

26.2

516

2502

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.4

26.2

193

664

K28

ICPC

Limited function/disability (K)

1.8

26.1

388

1735

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.5

26.1

840

4579

T89

ICPC

Diabetes insulin dependent

1.7

26.0

482

2299

K56.2

ICD-10 Finland

Volvulus

2.9

26.0

130

368

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

26.0

959

5371

K56.0

ICD-10 Finland

Paralytic ileus

2.4

25.9

183

617

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

25.9

6009

42901

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

25.9

2518

16411

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

25.9

702

3685

W17

ICD-10 Finland

Other fall from one level to another

1.6

25.9

615

3130

M10.9

ICD-10 Finland

Gout, unspecified

1.4

25.8

1329

7904

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1.6

25.7

667

3467

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.6

25.7

112

WF004

NOMESCO Finland

Palliative radiotherapy

1.8

25.7

367

1622

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

4.1

25.6

146

R4130

NOMESCO Finland

Speech therapy

1.8

25.6

368

1629

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

25.5

1006

5707

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.5

25.5

167

544

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

25.4

2085

13291

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

25.4

815

4437

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.2

25.4

233

879

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

25.4

570

2860

UJD02

NOMESCO Finland

Gastroscopy

1.6

25.4

692

3637

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.0

25.4

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

25.4

226

843

N03AX14

ATC

levetiracetam; systemic

1.8

25.4

420

1941

N05AE04

ATC

ziprasidone; systemic

4.3

25.3

130

OAB48, ,

SPAT

0.7

25.3

669

8152

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.8

25.2

133

388

C08CA05

ATC

nifedipine; systemic

1.4

25.2

1026

5856

H53.2

ICD-10 Finland

Diplopia

1.7

25.1

459

2181

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

25.1

139

416

C66

ICD-10 Finland

Malignant neoplasm of ureter

5.7

25.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

25.1

7407

53963

JGC01

NOMESCO Finland

Laparoscopic rectopexy

3.5

25.1

208

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.2

25.1

104

264

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.2

25.0

103

260

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

25.0

1210

7120

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.1

25.0

233

885

XG466

NOMESCO Finland

Sleep oxymetry

1.7

25.0

445

2100

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

25.0

1613

9941

C09BA02

ATC

enalapril and diuretics; systemic

1.4

25.0

1355

8129

R52.0

ICD-10 Finland

Acute pain

1.8

24.9

397

1814

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

24.9

534

2649

PA6AD

NOMESCO Finland

CT of neck arteries

1.6

24.9

542

2699

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1.9

24.9

349

1533

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

24.8

426

1989

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.6

24.7

109

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.5

24.7

730

3907

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.3

24.7

238

IEV99

NOMESCO Finland

Other psychiatric network intervention

4.8

24.6

100

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.1

24.6

228

865

P19

ICPC

Drug abuse

3.3

24.5

231

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

24.5

1786

11201

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

24.5

932

5252

X84

ICD-10 Finland

Intentional self-harm by unspecified means

5.5

24.4

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.3

24.4

186

650

N07BB01

ATC

disulfiram; oral

1.6

24.4

532

2651

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

8.3

24.4

S01

ICPC

Pain/tenderness of skin

1.6

24.4

623

3227

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.6

24.3

142

437

X57

ICD-10 Finland

Unspecified privation

1.9

24.3

320

1377

JG1JB

NOMESCO Finland

Defekography with X-ray

3.5

24.3

201

KBH20

NOMESCO Finland

Replantation of ureter

5.9

24.2

WGA11

NOMESCO Finland

Planning of pain management

3.4

24.2

217

N05AF05

ATC

zuclopenthixol; systemic

2.7

24.2

135

406

N06AX12

ATC

bupropion; oral

1.6

24.2

617

3194

P15

ICPC

Chronic alcohol abuse

1.8

24.2

388

1777

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

7.2

24.1

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.3

24.1

186

654

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.0

24.1

109

292

WX213

NOMESCO Finland

Lower leg blockade

2.5

24.0

152

487

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.9

24.0

297

1253

K02.1

ICD-10 Finland

Caries of dentine

1.2

23.9

7871

57782

R06AE07

ATC

cetirizine; oral

1.2

23.8

5456

38840

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

23.8

446

2135

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

23.7

417

1961

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.8

23.7

367

1664

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

23.7

576

2949

A10AD05

ATC

insulin aspart; parenteral

1.9

23.7

324

1413

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.8

23.6

120

343

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.2

23.6

253

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

4.1

23.6

134

RF220, ,

NOMESCO Finland

2.2

23.6

198

721

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

3.6

23.6

178

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

23.5

1320

7959

R4180

NOMESCO Finland

Podiatric therapy

2.3

23.5

179

625

F31

ICD-10 Finland

Bipolar affective disorder

2.7

23.5

131

394

C02CA01

ATC

prazosin; oral

1.9

23.5

310

1336

C10AC01

ATC

colestyramine; oral

1.8

23.5

332

1463

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

23.4

748

4069

XF402

NOMESCO Finland

ECG with work load test

1.3

23.4

1575

9761

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

23.4

3982

27570

M89.0

ICD-10 Finland

Algoneurodystrophy

3.1

23.4

100

259

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.7

23.3

168

S10

ICPC

Boil/carbuncle

1.5

23.3

782

4298

M54.8

ICD-10 Finland

Other dorsalgia

1.6

23.3

525

2638

KAC20

NOMESCO Finland

Nephroureterectomy

6.9

23.3

D16

ICPC

Rectal bleeding

1.9

23.2

326

1433

G04BD10

ATC

darifenacin; oral

3.4

23.2

215

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.8

23.2

339

1509

L84

ICD-10 Finland

Corns and callosities

1.7

23.2

471

2304

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

8.1

23.2

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.5

23.2

723

3915

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.9

23.1

295

1257

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.4

23.1

1175

6975

E87.2

ICD-10 Finland

Acidosis

2.9

23.0

110

304

J96.0

ICD-10 Finland

Acute respiratory failure

2.1

23.0

237

937

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.9

22.9

306

1324

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

22.9

1397

8533

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.1

22.9

237

938

L05

ICPC

Flank/axilla symptom/complaint

1.5

22.9

830

4633

C08CA13

ATC

lercanidipine; oral

1.3

22.9

2203

14327

RS221, ,

NOMESCO Finland

2.3

22.8

185

664

H3603, E103,

ICD-10 Finland

2.8

22.7

121

355

XX3XW, ,

NOMESCO Finland

3.0

22.7

102

272

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.0

22.7

238

947

N34.2

ICD-10 Finland

Other urethritis

5.8

22.6

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

2.9

22.6

110

307

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

22.6

431

2073

P28

ICPC

Limited function/disability (P)

2.9

22.6

112

316

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.1

22.6

208

787

P74

ICPC

Anxiety disorder/anxiety state

1.8

22.6

372

1718

N41.2

ICD-10 Finland

Abscess of prostate

10.9

22.5

M01AH01

ATC

celecoxib; oral

1.3

22.5

2307

15112

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

22.4

797

4431

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

2.6

22.4

134

418

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

22.4

429

2067

A07DA03

ATC

loperamide; oral

1.6

22.4

483

2401

LWW96

NOMESCO Finland

Other reoperation in gynaecological surgery

7.0

22.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

22.3

4835

34205

ZX112

NOMESCO Finland

Subcutaneous

1.9

22.3

301

1307

C02AC05

ATC

moxonidine; oral

1.5

22.2

711

3870

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.8

22.2

318

1407

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.3

22.2

116

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

22.1

1720

10877

N99.9

ICD-10 Finland

Postprocedural disorder of genitourinary system, unspecified

9.0

22.1

N81.4

ICD-10 Finland

Uterovaginal prolapse, unspecified

3.0

22.1

264

ZXY60

NOMESCO Finland

2-person team, nurses

4.5

22.1

103

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

4.8

22.0

L30.4

ICD-10 Finland

Erythema intertrigo

2.2

22.0

198

742

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

22.0

1421

8754

ZXY49

NOMESCO Finland

Other health care provider

4.5

22.0

100

KEB00

NOMESCO Finland

Biopsy of prostate

1.9

22.0

264

1103

KC1EE, ,

SPAT

2.7

21.9

121

362

S01BC05

ATC

ketorolac; ophthalmic

1.6

21.9

604

3183

-44

ICPC

Preventive immunization/medic

1.4

21.9

1150

6859

I95.2

ICD-10 Finland

Hypotension due to drugs

2.5

21.9

148

490

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

21.9

331

1490

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

21.9

393

1861

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

21.8

929

5344

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

21.8

3800

26341

D07AA02

ATC

hydrocortisone; topical

1.3

21.8

1681

10620

N19

ICPC

Speech disorder

2.1

21.7

207

794

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

21.7

2885

19455

N05AF01

ATC

flupentixol; systemic

2.2

21.7

188

694

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.1

21.7

216

843

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

21.7

752

4162

T91.1

ICD-10 Finland

Sequelae of fracture of spine

4.5

21.6

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.5

21.6

640

3427

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.3

21.6

177

639

S19

ICPC

Skin injury other

1.6

21.5

557

2895

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

21.5

1662

10502

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

2.9

21.5

104

290

I50.1

ICD-10 Finland

Left ventricular failure

1.4

21.5

968

5627

J01FA06

ATC

roxithromycin; oral

1.2

21.5

5425

38867

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

4.7

21.4

B01AB04

ATC

dalteparin; parenteral

1.5

21.4

708

3879

C09CA01

ATC

losartan; oral

1.2

21.4

3958

27579

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.5

21.4

731

4032

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

5.9

21.4

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.6

21.4

167

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.4

21.4

158

545

S37.2

ICD-10 Finland

Injury of bladder

9.0

21.4

F44.4

ICD-10 Finland

Dissociative motor disorders

9.0

21.4

X78

ICD-10 Finland

Intentional self-harm by sharp object

3.7

21.4

152

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4099

17988

2.08

322.46

6.9

5.9

1.05

1.03

mmol/l

2.38

3845

16732

(3022948) Iron [Moles/volume] in Serum or Plasma

5068

24060

1.97

320.07

3.0

2.6

11.06

12.75

umol/l

56.65

4667

22289

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10716

64582

1.81

314.61

7.1

5.7

5.86

3.47

ug/l

3.46

9879

57534

(3013650) Neutrophils [#/volume] in Blood by Automated count

11288

69106

1.82

314.53

11.3

9.4

4.73

4.32

e9/l

40.28

9862

59460

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4812

22611

1.97

311.70

3.0

2.6

2.18

2.26

g/l

21.10

4415

20811

(3029937) Albumin [Presence] in Urine by Test strip

6829

36024

1.84

310.54

7.0

3.8

0.00

estimate

0.35

2605

11607

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5162

20224

2.47

307.65

5.8

2.8

1.68

1.85

e6/l

0.80

3163

9622

(3002582) Erythrocytes [#/volume] in Urine

9856

41515

2.96

307.65

6.3

3.0

152.04

62.54

e6/l

5.98

8375

31616

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5483

23704

2.23

307.65

2.4

1.9

—

(3032080) INR in Blood by Coagulation assay

11427

64325

2.13

307.65

21.0

17.9

1.33

1.34

inr

0.47

9993

54068

(3041096) Erythrocytes [Presence] in Urine by Automated

6303

31893

1.90

307.65

6.1

3.1

0.40

0.18

estimate

0.58

2275

10357

(3015736) pH of Urine

9719

50062

2.20

307.65

5.5

3.3

6.29

6.22

6.63

5519

27168

(3023368) Bacteria identified in Blood by Culture

9159

39497

2.73

307.65

6.1

4.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

10821

45280

3.24

307.65

6.1

3.1

3.97

1.12

e6/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10441

58536

2.01

307.65

8.8

6.8

1.20

mmol/l

6.65

9706

53954

(3024561) Albumin [Mass/volume] in Serum or Plasma

10428

58520

2.01

307.65

6.3

5.1

33.75

34.96

g/l

75.22

9781

54635

(3031040) Bacteria [#/volume] in Urine by Automated count

14794

78244

3.61

307.65

9.8

4.0

1424.95

1698.41

e6/l

0.31

353

1214

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3033

10232

2.67

307.65

3.8

2.2

0.41

0.47

e6/l

0.76

2961

9858

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11508

65132

2.13

307.65

9.8

7.3

1.20

1.21

mmol/l

5.07

9932

55891

(3035350) Ketones [Presence] in Urine by Test strip

11638

63076

2.32

307.65

6.7

3.6

5.25

4.37

estimate

0.22

3025

13398

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7557

40031

1.89

307.65

3.5

2.7

69.98

64.21

u/l

0.23

7067

37075

(36304419) Bacteria [Presence] in Urine

8175

33699

2.72

307.65

6.0

2.9

1663.43

94.02

estimate

0.71

164

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4100

17813

2.10

307.65

2.2

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

7699

28473

3.03

307.65

4.3

2.5

3.95

4.36

e6/l

2.70

7203

25863

(3021601) Nitrite [Presence] in Urine by Test strip

11524

62314

2.31

307.65

6.6

3.6

0.00

estimate

0.06

2893

13151

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8568

46954

1.88

307.65

7.0

3.6

1.40

0.25

estimate

1.51

2344

11055

(3026782) Osmolality of Urine

6703

24242

2.93

307.65

4.7

2.6

516.83

552.73

mosm/kgh2o

37.26

6085

21233

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7001

35549

1.95

307.65

2.6

2.4

2.96

2.91

mg/l

0.89

6055

30512

(3037467) Urinalysis macro (dipstick) panel - Urine

14310

81302

2.85

307.65

8.1

4.1

2.05

2.31

0.23

113

(3018095) Leukocytes [#/volume] in Urine

10277

45970

2.81

307.65

7.3

3.5

221.01

86.47

e6/l

19.83

8455

32699

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5496

22450

2.39

307.65

5.5

2.7

1.20

e6/l

0.00

3514

11906

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11494

66485

2.04

307.65

7.9

6.8

11.63

12.76

umol/l

15.77

11011

63431

(3013826) Glucose [Moles/volume] in Serum or Plasma

12864

75736

2.22

307.65

7.6

5.3

7.03

6.87

mmol/l

9.55

12474

72071

(3009261) Glucose [Presence] in Urine by Test strip

11651

63461

2.30

307.65

6.7

3.6

0.38

0.47

estimate

0.08

2792

12436

(3049717) Cytology report of Urine Cyto stain

2307

2995

6.97

307.65

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

8649

35868

2.78

307.65

6.0

3.0

0.35

0.51

e6/l

9.23

7229

26289

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10424

57034

2.09

307.65

3.6

2.8

—

estimate

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14228

94112

1.95

304.53

11.1

8.4

85.68

81.29

u/l

9.69

13622

89113

(3014051) Protein [Presence] in Urine by Test strip

6095

31206

1.86

303.12

4.6

2.8

0.17

0.06

1.89

185

969

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4524

20992

1.98

302.42

3.1

2.7

20.38

22.71

27.48

4149

19437

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4713

22194

1.96

301.84

3.5

3.4

0.81

0.82

mmol/l

3.54

4405

20850

(3020779) Urea [Moles/volume] in Serum or Plasma

3248

13365

2.17

299.40

7.5

6.9

11.71

10.89

mmol/l

6.74

3080

12702

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3449

14555

2.12

297.96

5.0

3.7

5.80

kpa

0.04

3330

14210

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5992

30802

1.85

291.81

3.2

2.5

—

(3018418) pH of Serum or Plasma

7163

38882

1.80

291.75

5.6

4.3

7.40

0.27

5434

27861

(3021960) Folate [Moles/volume] in Serum or Plasma

7119

38580

1.80

291.48

2.0

1.7

18.78

19.63

nmol/l

4.98

6175

32646

(3002032) Base excess in Venous blood by calculation

3360

14155

2.12

290.85

5.1

3.8

1.50

1.72

mmol/l

2.49

2909

12320

(3012544) pH of Venous blood

3470

14809

2.10

290.34

5.0

3.8

7.37

7.38

3.24

2154

8620

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2521

9454

2.34

289.52

1.8

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7450

41038

1.78

287.60

2.8

2.2

240.38

232.71

u/l

0.21

7107

38673

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3779

16741

2.04

285.49

2.3

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4291

19903

1.97

284.68

8.1

7.3

104.14

104.43

mmol/l

3.24

4286

19891

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7822

43958

1.76

279.46

3.8

3.3

2145.90

1679.49

ng/l

10.00

6908

38380

(3019069) Monocytes/Leukocytes in Blood

9605

57232

1.74

278.80

7.6

6.5

9.07

9.16

1.96

9018

53443

(3006504) Eosinophils/Leukocytes in Blood

9582

57063

1.74

278.61

7.5

6.4

2.69

2.86

9.18

9007

53281

(3022096) Basophils/Leukocytes in Blood

9578

57080

1.74

277.25

7.6

6.4

0.59

0.65

23.12

8992

53294

(3018010) Neutrophils/Leukocytes in Blood

9525

57053

1.72

266.58

7.4

6.3

60.67

58.39

57.48

9098

54373

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8729

51051

1.72

266.40

6.1

4.1

64.40

93.31

ng/l

1.24

7261

39258

(3002030) Lymphocytes/Leukocytes in Blood

9690

58325

1.72

266.32

7.6

6.4

23.85

26.25

76.07

9190

55076

(3014111) Lactate [Moles/volume] in Serum or Plasma

3062

12881

2.10

263.57

7.6

1.36

1.39

mmol/l

0.80

2992

12594

(3019309) Folate [Moles/volume] in Red Blood Cells

4918

24384

1.86

263.53

1.9

1.8

1153.45

1149.76

nmol/l

0.09

3739

18487

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8759

51431

1.71

261.88

5.5

4.7

21.91

22.31

1.76

5417

26821

(3013115) Eosinophils [#/volume] in Blood

10400

63999

1.71

261.69

7.5

6.3

0.20

e9/l

0.15

9030

55269

(3019198) Lymphocytes [#/volume] in Blood

10325

63487

1.71

259.69

7.4

6.2

1.75

1.90

e9/l

10.71

9041

55257

(3006315) Basophils [#/volume] in Blood

10183

62381

1.71

259.63

7.3

6.1

0.04

e9/l

5.69

8720

53048

(3007853) Bacteria identified in Skin by Aerobe culture

3412

15027

2.02

259.15

2.1

1.8

—

(3001604) Monocytes [#/volume] in Blood

10142

62140

1.70

257.54

7.2

6.1

0.64

0.63

e9/l

6.28

8681

52800

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2424

9403

2.25

255.03

4.6

3.8

5.14

5.13

kpa

0.12

2298

8936

(3000991) Gas panel - Venous blood

2917

12241

2.10

251.69

9.3

9.0

—

(3009343) pH of Capillary blood

2361

9139

2.25

249.32

4.6

3.8

7.41

7.42

1.40

2025

7665

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9555

58190

1.67

241.89

2.6

2.2

90.81

93.52

pmol/l

7.05

5733

32217

(3045414) Leukocytes [Presence] in Urine

2688

11134

2.11

238.95

2.8

1.9

0.03

0.01

estimate

0.93

412

2197

(3024354) Oxygen [Partial pressure] in Venous blood

2858

12135

2.07

237.89

4.1

3.1

4.54

4.44

kpa

1.26

2745

11810

(3019977) pH of Arterial blood

3743

17495

1.91

237.03

7.8

7.7

7.41

7.42

2.05

2086

9745

(3003396) Base excess in Arterial blood by calculation

3721

17388

1.91

235.64

7.8

7.6

0.76

0.92

mmol/l

1.36

3050

14191

(3002256) Pathology report gross observation

3434

15640

1.95

234.57

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3733

17513

1.90

233.32

7.8

7.7

5.06

kpa

0.03

3586

16795

(3027801) Oxygen [Partial pressure] in Arterial blood

3731

17502

1.90

233.25

7.8

7.7

11.75

12.05

kpa

3.10

3579

16776

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8951

53990

1.66

231.08

3.8

3.1

160.07

159.51

ug/l

0.05

8183

49839

(3015377) Calcium [Moles/volume] in Serum or Plasma

7412

42575

1.68

231.05

4.0

3.5

2.34

2.35

mmol/l

7.85

6728

38404

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2107

8029

2.26

229.85

4.4

3.6

1.89

1.82

mmol/l

0.36

1567

5868

(3027945) Reticulocytes/Erythrocytes in Blood

3769

17836

1.89

228.87

2.5

2.4

1.78

1.76

0.44

3312

15813

(3033658) Prothrombin time (PT) actual/Normal

5874

31871

1.72

224.85

5.8

4.2

82.87

84.31

4.11

5762

31227

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4295

21379

1.81

220.99

2.2

2.0

30.39

29.88

6.10

4189

20785

(3016502) Oxygen saturation in Arterial blood

3375

15727

1.90

213.09

8.0

95.27

95.30

0.08

3264

15173

(3042936) Bacteria identified in Isolate by Culture

3901

19275

1.81

203.29

2.5

2.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16020

114853

1.93

198.20

33.2

17.5

30.44

28.03

mg/l

16.35

14888

96326

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2202

9036

2.10

198.01

7.9

8.3

24.55

24.67

mmol/l

0.69

2178

8968

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2035

8103

2.16

197.71

5.2

3.9

23.85

24.08

mmol/l

2.35

1994

7996

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1442

4951

2.47

197.63

3.5

3.0

24.57

24.66

mmol/l

0.33

1413

4865

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6504

37392

1.62

192.08

3.7

3.3

0.95

0.79

ug/l

13.34

5134

25802

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3564

17400

1.81

191.83

3.9

4.5

241.59

247.41

u/l

0.92

3341

16515

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3084

14414

1.87

190.74

8.6

119.37

121.80

g/l

8.69

3029

14076

(3011397) Hemoglobin [Presence] in Urine by Test strip

5363

29536

1.66

186.62

6.0

3.5

0.26

0.30

0.09

374

(3003181) Sodium [Moles/volume] in Urine

841

2272

3.09

181.26

1.5

1.3

56.05

64.04

mmol/l

7.09

678

1846

(3023520) Reticulocytes [#/volume] in Blood

2972

13945

1.86

180.63

2.5

2.6

67.23

68.21

e9/l

0.80

2167

10398

(3028626) Oxygen [Partial pressure] in Capillary blood

1099

3448

2.68

180.61

3.8

3.1

7.99

7.89

kpa

1.17

1075

3369

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2104

8826

2.05

177.22

8.7

9.5

24.07

24.20

mmol/l

0.92

2036

8594

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1630

6197

2.23

176.57

2.1

1.9

2.46

2.02

ug/l

0.62

1412

5505

(4024509) Urine culture

1401

4995

2.37

176.17

2.9

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1216

4067

2.52

175.54

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2872

13563

1.84

170.06

5.2

3.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2340

10358

1.95

168.83

2.4

2.5

380.78

382.31

nmol/l

0.11

2164

9616

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4738

25991

1.64

163.29

5.4

4.1

411.45

563.65

ng/l

1.19

4100

21989

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8233

51515

1.52

158.78

2.7

2.3

77.05

77.62

nmol/l

0.98

7288

45881

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12732

87572

1.56

157.05

5.1

4.4

16.16

13.08

mm/h

63.28

11812

81271

(3021901) Oxygen saturation in Capillary blood

953

3006

2.65

154.52

3.5

3.0

89.66

88.87

2.88

933

2930

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4616

25541

1.61

151.66

3.3

3.2

2.46

2.45

mmol/l

5.42

4071

22770

(3004119) Hemoglobin [Mass/volume] in Venous blood

2056

9016

1.95

151.41

4.2

3.2

125.25

129.37

g/l

12.66

1992

8739

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6598

39694

1.53

150.17

3.9

3.3

32.86

36.15

u/l

2.91

6203

37223

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4591

25527

1.60

147.04

1.9

1.7

1.56

1.46

mg/l

0.88

3700

20159

(40761536) Microorganisms panel - Urine sediment

2119

9562

1.89

142.76

7.2

3.6

—

(40768804) Tissue Pathology biopsy report

7386

45968

1.50

140.30

2.4

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2584

12488

1.78

139.38

2.5

2.7

65.67

66.20

g/l

2.74

2350

11420

(1616796) Gas panel - Central venous blood

954

3172

2.51

138.72

4.3

3.9

—

(3021589) Normoblasts [#/volume] in Blood

8362

53547

1.48

136.61

18.3

12.0

0.00

e9/l

0.43

6869

43525

(3019150) Specific gravity of Urine by Refractometry

4912

28147

1.56

136.36

7.1

3.9

1.02

1.18

kg/l

1.07

3759

18597

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2599

12700

1.76

134.61

2.3

0.20

g/l

2.31

2360

11794

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1337

5222

2.15

134.18

2.3

2.2

534.03

694.27

ug/l

1.02

1282

4994

(3045424) Erythrocytes [Presence] in Urine

1404

5603

2.11

133.31

2.8

2.0

0.02

estimate

0.12

322

1612

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2842

14311

1.71

132.11

2.9

2.8

9.25

10.43

umol/l

1.71

2478

12647

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1676

7171

1.98

131.56

1.7

1.6

1.64

1.54

g/l

3.93

1424

6148

(3022621) pH of Urine by Test strip

1986

9020

1.87

130.45

3.8

2.5

6.04

6.03

0.27

1465

6334

(3022313) Gas panel - Capillary blood

1540

6441

2.02

128.76

4.9

3.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

16120

119126

1.72

126.84

39.1

21.3

139.05

139.64

mmol/l

123.77

15909

116641

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2023

9368

1.84

124.66

4.7

4.0

113.34

96.41

ng/l

6.69

1741

8011

(3023103) Potassium [Moles/volume] in Serum or Plasma

16129

119325

1.71

124.59

39.3

21.5

4.02

4.01

mmol/l

13.09

15905

116669

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2359

11485

1.76

122.86

3.1

2.5

64.82

49.87

u/l

0.21

2017

9743

(40767503) Oxygen content in Capillary blood by calculation

863

2910

2.47

121.57

3.1

2.7

15.97

16.22

1.49

846

2847

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2025

9511

1.81

118.82

9.7

9.9

0.59

0.63

5.35

2005

9451

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1263

5061

2.09

118.20

3.2

2.9

0.34

iu/ml

0.02

704

2826

(3024928) Oxygen saturation in Venous blood

945

3388

2.32

116.16

3.4

3.1

60.75

61.07

0.15

889

3256

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1706

7645

1.88

116.11

3.6

2.8

1.26

1.20

1.43

1699

7606

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1691

7560

1.89

115.91

3.6

2.8

0.62

0.63

0.50

1685

7531

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2071

9876

1.78

115.30

9.5

9.6

1.30

1.33

0.91

2051

9813

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4744

27847

1.51

113.95

1.9

1.8

11772774.83

29481452.32

pmol/l

2.51

3848

22930

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1839

8491

1.83

113.81

10.1

10.2

15.77

16.09

5.42

1796

8192

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1199

4811

2.08

111.63

2.2

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1263

5235

2.02

107.61

2.4

2.0

—

(3000330) Specific gravity of Urine by Test strip

1473

6463

1.91

106.50

5.6

3.1

1.02

ratio

7.50

1348

5862

(3014007) Fractional oxyhemoglobin in Arterial blood

2034

9895

1.74

105.11

9.8

9.7

93.77

93.72

0.14

2029

9860

(3027273) Bicarbonate [Moles/volume] in Venous blood

1514

6775

1.88

102.96

4.6

3.4

25.03

25.11

mmol/l

0.37

1453

6573

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9006

60496

1.39

100.81

3.1

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2107

10543

1.69

97.91

5.1

3.9

1.22

mmol/l

3.28

1840

9034

(3006184) Hemoglobin [Mass/volume] in Capillary blood

897

3394

2.19

96.72

2.7

2.3

126.82

128.74

g/l

1.45

766

2585

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

612

1952

2.59

96.54

6.5

6.1

11.88

11.96

mg/l

0.16

564

1812

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10729

74543

1.39

95.88

4.3

3.3

60.83

55.76

u/l

3.99

9959

69121

(3023183) Ammonium ion [Moles/volume] in Plasma

846

3142

2.23

95.43

2.5

2.4

31.02

33.27

umol/l

1.75

746

2808

(3028271) Lactate [Moles/volume] in Capillary blood

639

2107

2.50

94.13

2.2

1.9

1.66

1.76

mmol/l

1.59

623

2047

(40758558) Short blood count panel - Blood

5792

36374

1.42

93.95

8.8

6.4

—

(3010421) pH of Blood

1057

4319

2.04

93.32

4.7

3.8

7.41

0.06

1033

4258

(3013512) EKG study

6985

45391

1.39

92.46

5.2

3.9

0.69

0.77

0.29

139

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1596

7581

1.77

88.84

5.6

3.9

46.30

46.58

0.17

1567

7470

(3027315) Oxygen [Partial pressure] in Blood

787

2927

2.23

88.39

4.8

4.2

8.38

8.45

kpa

0.54

762

2859

(3008295) Osmolality of Serum or Plasma

448

1272

2.89

88.14

1.3

276.94

277.97

mosm/kgh2o

0.33

329

982

(3013290) Carbon dioxide [Partial pressure] in Blood

783

2912

2.22

87.95

4.8

4.2

4.96

4.98

kpa

0.34

759

2844

(3012501) Base excess in Blood by calculation

782

2911

2.22

87.63

4.8

4.2

2.59

mmol/l

0.00

519

1969

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1162

5032

1.92

86.81

5.1

4.0

24.76

24.80

mmol/l

0.13

1066

4570

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16214

122250

1.57

85.60

41.6

23.4

92.32

84.56

umol/l

69.69

16041

120527

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2223

11699

1.61

83.92

3.3

3.1

278.08

241.10

ng/l

2.23

2040

10742

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

730

2717

2.22

81.78

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

730

2717

2.22

81.78

1.5

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1876

9552

1.65

80.64

7.7

7.1

24.31

24.41

mmol/l

0.49

1801

9159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14223

104914

1.41

78.95

5.7

4.9

2.00

2.01

mu/l

0.52

12969

95551

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2348

12695

1.57

78.67

2.9

2.4

7.20

7.66

ug/l

0.41

1974

11163

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

14812

110110

1.43

78.06

31.6

17.4

73.44

76.65

ml/min/173m2

55.61

14190

102247

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1413

6734

1.75

77.33

5.9

5.0

1.65

1.61

0.60

1360

6375

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11870

85254

1.35

75.86

4.5

4.0

15.06

14.93

pmol/l

6.04

10704

77170

(3037121) Protein [Mass/volume] in Urine

996

4298

1.92

74.95

3.3

3.2

1208.46

477.15

mg/l

0.91

481

2108

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

961

4119

1.93

73.76

1.9

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1153

5256

1.82

73.14

2.8

3.5

69.43

68.31

mg/l

0.03

954

4472

(3017181) Myelocytes/Leukocytes in Blood

2171

11711

1.56

73.08

4.6

4.2

0.97

0.96

0.02

802

3828

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1152

5252

1.82

73.05

2.8

3.5

58.07

46.45

mg/l

0.52

952

4462

(3002179) Metamyelocytes/Leukocytes in Blood

2075

11110

1.57

72.09

4.4

4.1

0.70

0.69

0.06

769

3593

(3044889) 12 lead EKG panel

11755

84589

1.34

72.00

5.4

4.5

0.41

3410.00

1.18

224

(3007930) Methemoglobin/Hemoglobin.total in Blood

1295

6159

1.75

71.19

6.1

5.3

0.88

0.87

0.52

1245

5809

(3021440) Promyelocytes/Leukocytes in Blood

2069

11139

1.56

70.05

4.6

4.2

0.12

0.11

0.12

702

3279

(3020682) Albumin/Creatinine [Ratio] in Urine

6953

46554

1.33

69.70

4.8

4.3

14.19

8.74

mg/mmol

13.04

4850

30053

(3025159) Blasts/Leukocytes in Blood

2067

11167

1.56

68.84

4.8

4.4

0.14

0.27

1.04

679

3081

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15910

120533

1.47

68.50

16.4

12.5

25.20

26.53

u/l

8.66

15432

116466

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1040

4687

1.84

68.34

2.8

3.4

2.96

4.76

ratio

1.05

573

2708

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1266

6079

1.73

67.17

2.1

2.5

7.46

7.40

g/l

0.61

1145

5525

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1265

6075

1.73

67.08

2.1

2.5

4.16

g/l

0.08

1146

5529

(3007461) Platelets [#/volume] in Blood

16254

123760

1.50

67.05

47.0

26.6

240.60

239.18

e9/l

1.81

15981

120685

(40768797) Stomach Pathology biopsy report

2837

16461

1.46

67.04

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16256

123785

1.50

66.94

47.9

27.1

38.66

40.50

66.70

16081

122024

(3035941) MCH [Entitic mass]

16255

123776

1.50

66.94

46.8

26.4

30.32

30.51

31.69

16086

122073

(3019230) Fractional oxyhemoglobin in Venous blood

715

2854

2.07

66.93

3.3

2.6

60.84

62.05

0.69

710

2841

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16256

123787

1.50

66.91

46.9

26.5

91.55

91.64

1.41

16087

122086

(3026361) Erythrocytes [#/volume] in Blood

16256

123790

1.50

66.87

47.0

26.5

4.31

4.47

e12/l

237.30

15934

120171

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1262

6064

1.73

66.78

2.0

2.5

3.79

g/l

0.00

1143

5511

(3000963) Hemoglobin [Mass/volume] in Blood

16256

123805

1.50

66.63

47.4

26.7

129.05

135.27

g/l

307.65

16102

122121

(3010813) Leukocytes [#/volume] in Blood

16256

123810

1.49

66.56

47.1

26.6

7.33

6.93

e9/l

51.42

15943

120214

(3052851) Hemolysis interference index of Serum or Plasma

835

3532

1.95

66.51

4.4

3.5

1.76

2.00

index

0.60

494

1817

(3005719) IgG [Mass/volume] in Serum or Plasma

1744

9136

1.60

66.16

2.9

2.8

10.66

10.80

g/l

0.53

1593

8429

(3022806) Fractional oxyhemoglobin in Capillary blood

472

1602

2.42

65.30

2.1

1.8

89.29

88.98

0.46

462

1578

(3003694) ABO and Rh group [Type] in Blood

5159

33331

1.35

64.59

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

6971

47053

1.32

64.44

3.9

3.5

6.95

7.86

mmol/l

61.36

5780

39421

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1184

5668

1.74

63.40

2.1

2.5

2.98

2.91

g/l

1.36

1066

5118

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1108

5212

1.76

63.07

2.3

2.6

0.80

1.03

g/l

1.38

940

4424

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

631

2474

2.10

61.90

1.5

1.4

21.23

30.34

e6/l

0.45

486

1875

(3040151) Glucose [Moles/volume] in Capillary blood

474

1654

2.35

61.67

24.9

6.2

7.52

7.44

mmol/l

0.17

415

1345

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

635

2506

2.09

61.23

1.6

1.4

3802.34

2947.07

e6/l

0.09

522

2017

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

641

2549

2.07

60.57

1.3

3.97

3.84

mmol/l

1.82

597

2417

(3016038) Potassium [Moles/volume] in Urine

292

813

2.93

59.55

1.2

31.81

35.61

mmol/l

2.17

251

714

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

695

2868

2.00

59.35

1.4

1.3

587.57

562.43

mg/l

0.24

658

2746

(3019225) pH of Specimen

2172

12261

1.49

58.27

5.2

4.2

7.37

7.36

2.44

1679

8858

(3012516) Albumin [Mass/volume] in Urine

6724

45618

1.30

57.97

3.9

3.6

76.12

51.18

mg/l

11.12

4899

30459

(3026493) Urate [Moles/volume] in Serum or Plasma

5357

35340

1.32

56.35

3.2

3.0

369.05

361.18

umol/l

5.30

4615

30836

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2478

14490

1.44

55.21

4.1

4.4

18.86

32.41

ug/l

1.68

2087

12139

(3007164) IgA [Mass/volume] in Serum or Plasma

3333

20525

1.38

55.19

1.7

1.5

2.72

2.65

g/l

0.73

2037

12444

(3017732) Neutrophils [#/volume] in Blood

2561

15082

1.43

54.88

3.7

3.1

5.21

4.79

e9/l

1.09

2132

12847

(1761482) Bacteria [#/volume] in Urine by Culture

772

3392

1.88

54.77

7.3

3.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1082

5286

1.69

53.62

2.0

2.5

10.39

10.35

g/l

0.12

945

4685

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12633

93351

1.29

53.60

39.2

21.6

14.14

13.79

120.33

12537

91975

(3009466) Valproate [Moles/volume] in Serum or Plasma

453

1649

2.25

53.47

5.7

4.5

353.40

343.70

umol/l

0.72

391

1424

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

821

3736

1.81

52.07

3.6

3.0

1.91

1.67

mg/l

10.35

737

3354

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

204

498

3.34

51.78

2.6

1.7

126.28

114.61

umol/l

0.25

113

252

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

930

4402

1.74

51.61

2.1

2.5

0.02

0.04

g/l

0.94

821

3922

(3028026) IgM [Mass/volume] in Serum or Plasma

1364

7139

1.59

51.40

2.1

2.0

1.41

1.35

g/l

0.32

1246

6526

(21494755) Public health laboratory ask at order entry panel

407

6898

0.47

51.21

1.4

—

(3047181) Lactate [Moles/volume] in Blood

909

4330

1.73

49.30

6.6

6.1

1.36

1.35

mmol/l

0.03

811

3845

(4035726) Immunohistochemistry procedure

1889

10727

1.47

48.64

1.4

—

(3000012) Reticulocyte production index

565

2332

1.99

48.19

2.0

2.3

0.91

0.90

0.15

422

1626

(3014271) Vancomycin [Susceptibility]

243

689

2.88

48.06

3.4

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

803

3724

1.78

47.78

1.5

1.4

257.98

257.86

ug/g

0.00

471

2275

(4198724) Urine methamphetamine measurement

140

278

4.09

47.71

2.5

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

890

4276

1.72

46.78

2.1

2.5

0.00

g/l

0.31

770

3715

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3610

23024

1.33

46.56

1.3

1.59

1.84

u/ml

0.71

929

5974

(3008037) Lactate [Moles/volume] in Venous blood

790

3675

1.77

46.50

4.7

3.1

1.60

1.66

mmol/l

1.18

772

3579

(3000494) Fungus identified in Specimen by Culture

2442

14648

1.40

46.49

1.6

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

363

1277

2.32

46.43

2.7

2.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1104

5640

1.62

45.86

1.5

1.6

15.74

12.96

iu/ml

0.23

131

(3037756) Immunofixation for Serum or Plasma

713

3238

1.81

45.48

1.5

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

741

3411

1.79

45.19

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

1106

5684

1.61

44.82

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

770

3596

1.76

44.71

1.5

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

184

463

3.23

44.59

21.8

19.0

1416.50

1382.71

nmol/l

0.22

175

447

(3028707) Methadone [Presence] in Urine by Screen method

311

1056

2.40

43.08

3.9

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2662

16412

1.36

42.53

1.9

1.8

—

(3003129) Base excess in Capillary blood by calculation

424

1650

2.10

42.44

2.5

2.3

0.54

0.24

mmol/l

0.73

401

1581

(40760892) CBC W Ordered Manual Differential panel - Blood

3962

25908

1.30

42.05

5.7

4.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

821

3993

1.69

41.22

2.1

2.6

0.00

g/l

-0.00

769

3708

(40768800) Prostate Pathology biopsy report

857

4231

1.67

40.66

1.1

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

172

440

3.18

40.63

16.4

14.0

844.52

3813.17

nmol/l

0.49

167

418

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14413

109570

1.28

40.48

8.3

7.0

41.50

40.13

mmol/mol

47.05

13311

101491

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

321

1141

2.30

40.14

1.6

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

2443

15012

1.36

39.62

1.4

1.3

506.06

490.93

titre

0.15

554

3151

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

930

4722

1.62

39.51

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

763

3690

1.70

39.10

1.6

1.4

16.69

13.99

iu/ml

0.18

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

639

2940

1.78

39.02

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

974

5026

1.60

38.71

4.4

4.2

1.38

1.42

mmol/l

0.48

940

4924

(3038515) Glucose [Moles/volume] in Venous blood

661

3094

1.75

38.06

5.1

3.2

8.04

7.70

mmol/l

1.93

646

3016

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

758

3693

1.69

37.79

2.5

2.4

3.68

3.62

g/l

0.47

726

3533

(3017143) Hepatitis C virus Ab [Presence] in Serum

1935

11536

1.40

37.63

1.8

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1035

5466

1.56

37.23

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14598

111514

1.27

36.65

6.0

5.5

6.25

6.08

mmol/l

31.80

13115

101380

(3020891) Body temperature

1290

7170

1.49

36.56

5.4

4.7

36.93

36.90

°c

1.46

1270

7099

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

675

8888

0.60

36.20

2.0

2.1

3.45

3.51

ratio

0.66

540

7060

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

216

670

2.62

36.19

2.5

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

752

3707

1.67

35.86

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

2082

12689

1.37

35.27

2.3

2.4

177.03

153.44

ug/g

1.63

1625

10074

(40761539) Cells [Type] in Urine sediment by Light microscopy

120

267

3.65

35.13

1.3

1.2

—

(3022145) Colonoscopy Study observation

2250

13935

1.35

34.30

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1226

6835

1.48

34.17

2.5

2.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

248

857

2.36

33.15

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

244

838

2.37

33.07

1.3

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2292

14307

1.34

33.06

1.8

1.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

162

454

2.90

32.87

16.0

13.5

0.64

0.63

mmol/l

0.07

149

416

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

703

3518

1.64

31.62

1.4

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

418

1806

1.89

31.27

1.5

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

269

994

2.20

30.79

2.6

1.8

2.15

1.35

u/field

1.44

156

535

(3044927) Protein electrophoresis panel - Urine

344

1402

2.00

30.51

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

507

2349

1.77

30.28

3.5

1.51

1.59

0.19

461

2069

(3020876) Protein [Mass/time] in 24 hour Urine

435

1927

1.84

30.12

2.2

2.4

1.08

1.23

g/24h

0.76

250

1149

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1982

12272

1.34

30.01

2.1

1.8

1.64

1.57

2.68

1659

10498

(3020191) Ethanol [Moles/volume] in Serum or Plasma

272

1021

2.17

29.97

2.3

1.3

1.20

promille

0.00

223

815

(3023410) Appearance of Cerebral spinal fluid

268

1015

2.15

28.89

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

532

2534

1.72

28.84

1.5

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

461

6313

0.58

28.71

1.7

1.8

3.37

3.39

mmol/l

0.12

334

4463

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

522

2478

1.72

28.65

1.3

1.2

150.43

306.66

titre

2.36

178

(3036489) Thrombin time

839

4489

1.53

28.40

2.1

2.0

21.74

21.47

0.37

771

4035

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

522

2487

1.72

28.28

1.3

130.00

94.78

titre

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

554

2.57

28.26

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

659

3338

1.62

28.24

1.5

1.6

0.24

g/l

0.15

611

3171

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

673

3454

1.60

27.33

1.6

1.17

1.18

g/l

0.38

628

3296

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

348

1491

1.90

26.76

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

411

1858

1.81

26.70

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

354

1527

1.89

26.67

1.5

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

518

2504

1.69

26.63

1.6

1.5

31.25

44.34

g/l

0.56

445

2288

(3027456) Digoxin [Moles/volume] in Serum or Plasma

621

3148

1.61

26.54

3.3

3.1

0.82

0.81

nmol/l

0.31

501

2485

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

463

2172

1.74

26.52

2.0

1.9

23.84

26.07

ug/l

0.29

450

2127

(3024522) Salmonella sp identified in Specimen by Organism specific culture

348

1497

1.90

26.45

1.5

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

179

592

2.46

26.44

2.3

1.7

2.95

2.12

u/field

0.80

122

415

(3044242) Glucose [Moles/volume] in Arterial blood

224

819

2.23

26.38

1.9

2.0

8.47

8.09

mmol/l

0.69

224

819

(3024891) Influenza virus A+B Ag [Presence] in Specimen

551

2716

1.66

26.32

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1062

6052

1.44

26.31

3.3

3.5

4.21

4.44

pmol/l

10.38

948

5416

(3043410) Blood group antigens tested for on Red Blood Cells

122

331

2.99

26.30

2.1

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

177

586

2.46

26.09

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

177

586

2.46

26.09

1.4

—

(3039000) Anion gap in Blood by calculation

600

3050

1.61

25.36

8.0

7.1

11.46

11.37

mmol/l

0.23

560

2745

(3018572) Chloride [Moles/volume] in Blood

600

3051

1.61

25.33

8.0

7.1

104.78

104.99

mmol/l

0.47

560

2746

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

443

2080

1.74

25.32

2.8

2.6

5894.57

5489.46

u/ml

0.03

139

(3043409) Potassium [Moles/volume] in Arterial blood

779

4214

1.52

25.06

5.0

4.5

3.93

mmol/l

0.11

765

4179

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

907

5062

1.47

25.05

3.2

3.6

866.51

2678.60

u/ml

1.34

802

4408

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

284

1167

1.98

24.71

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

648

3386

1.57

24.39

1.6

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

679

3589

1.55

24.29

2.2

89.47

89.74

0.11

656

3470

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

614

3173

1.58

24.24

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

233

901

2.10

23.91

1.4

1.2

2.15

2.23

mmol/l

0.47

209

838

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

601

2.37

23.87

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

220

834

2.15

23.76

1.9

2.3

15.65

15.87

0.43

220

834

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

328

1438

1.86

23.56

1.5

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1677

10481

1.32

23.54

3.5

2.8

57.09

63.29

ml/min/173m2

8.45

811

4487

(3005988) Vibrio sp identified in Specimen by Organism specific culture

328

1441

1.85

23.41

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

644

3397

1.55

23.26

2.5

2.4

156.58

117.04

ug/min

1.17

405

1967

(3025468) Yersinia sp identified in Specimen by Organism specific culture

325

1429

1.85

23.14

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

624

3276

1.56

23.02

2.6

2.4

207.08

202.40

0.60

591

3123

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

535

2711

1.61

22.94

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

528

2672

1.61

22.76

5.9

5.3

1277.13

1126.93

iu/ml

0.07

400

(3032057) Clostridioides difficile [Presence] in Stool

230

3.24

22.76

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

135

420

2.61

22.68

1.3

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

155

518

2.43

22.47

1.3

1.2

0.53

0.71

ratio

0.77

294

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

260

1077

1.96

22.17

1.2

—

(3004775) Volume in Urine collected for unspecified duration

263

1101

1.94

21.76

2.3

701.76

682.62

0.29

177

710

(3008757) Leukocyte morphology finding [Identifier] in Blood

315

1408

1.82

21.33

3.5

3.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

824

4660

1.45

21.25

1.8

1.6

0.29

0.32

mg/l

0.84

362

2281

(3004451) EKG impression Narrative

214

841

2.07

21.12

1.4

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2061

13435

1.27

20.86

2.4

2.2

10.61

13.06

nmol/l

27.42

1738

11950

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

234

958

1.99

20.66

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

194

741

2.13

20.62

1.2

1.1

56.14

46.55

mg/l

0.40

164

620

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

532

2768

1.57

20.45

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

501

2583

1.58

20.03

2.3

1.6

0.89

0.85

nmol/l

0.53

415

2189

(1001926) Buprenorphine [Presence] in Urine by Screen method

391

1898

1.68

19.89

3.5

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

874

5058

1.42

19.88

1.6

1.8

37.61

38.77

u/l

0.81

752

4392

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

163

591

2.24

19.72

1.7

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

353

1674

1.72

19.58

4.2

2.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

111

340

2.65

19.31

2.5

2.6

137.00

146.30

nmol/l

0.42

301

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1261

7780

1.33

19.26

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

327

1525

1.75

19.25

3.4

62.45

58.50

2.61

286

1295

(3023511) Choriogonadotropin [Units/volume] in Urine

223

923

1.96

19.13

1.7

1.3

—

(40768806) Pleura Pathology biopsy report

387

1894

1.67

19.11

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

175

666

2.13

18.83

1.1

—

(3042631) Mycobacterium sp identified in Specimen

417

2092

1.63

18.70

2.6

2.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

435

2209

1.61

18.57

1.6

1.5

4965.46

3123.88

e6/l

0.47

299

1593

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

271

1214

1.82

18.29

1.2

65.34

67.94

u/l

0.14

244

1060

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

228

2.99

18.24

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

595

3256

1.49

18.17

1.4

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

180

703

2.08

18.13

1.1

375.18

301.05

mg/l

0.86

159

617

(3011412) CD3 cells [#/volume] in Blood

248

1084

1.86

18.11

2.1

2.3

1125.62

1085.15

e6/l

0.33

214

985

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

353

1712

1.68

18.07

1.3

599.75

495.94

u/l

0.32

330

1625

(3014765) Yersinia sp identified in Stool by Organism specific culture

552

2979

1.51

18.03

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

329

1569

1.71

17.92

2.5

2.1

26.69

27.17

mg/l

0.06

118

613

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

477

2.31

17.83

3.3

2.8

9.89

10.25

kpa

0.58

136

477

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

144

518

2.26

17.81

1.3

1.2

54.33

64.06

0.43

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

478

2.31

17.75

3.3

2.8

4.96

4.93

kpa

0.11

136

478

(3051611) Lipemic interference index of Serum or Plasma

281

1285

1.78

17.73

4.4

3.5

12.90

12.93

index

0.01

189

694

(40768446) Kidney Pathology biopsy report

126

429

2.38

17.66

1.8

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

313

1480

1.72

17.59

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

234

2.91

17.46

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

393

1979

1.62

17.39

1.6

1.5

60040.93

63044.33

e6/l

0.07

222

1173

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1075

6577

1.34

17.37

2.0

1.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

550

2991

1.50

17.33

1.2

—

(36660697) Celiac disease serology panel - Serum

1285

8069

1.31

17.30

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

445

2314

1.57

17.21

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

545

2963

1.50

17.20

1.2

—

(3042517) Benzodiazepines panel - Urine

5.13

17.18

2.8

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

390

1972

1.61

16.98

1.6

1.7

0.85

0.87

g/l

0.13

291

1521

(3016879) Cocaine [Presence] in Urine

434

2257

1.57

16.79

3.4

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

343

1685

1.66

16.75

1.4

6.57

6.27

mmol/l

1.13

317

1566

(3035947) Staphylolysin Ab [Units/volume] in Serum

161

625

2.09

16.53

1.2

1.1

3.38

4.36

iu/ml

0.38

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

114

3.77

16.49

1.1

—

(3002619) Bacteria identified in Specimen by Culture

102

327

2.53

16.28

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

142

528

2.18

16.26

1.1

1.26

1.12

u/l

0.49

234

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

198

836

1.92

16.12

1.9

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

157

2478

0.51

16.05

1.1

0.72

0.63

ratio

0.61

387

(3016750) Collection duration of Urine

188

783

1.95

15.93

2.3

2.2

506.01

493.11

min

0.96

133

557

(3006576) Bicarbonate [Moles/volume] in Blood

138

513

2.18

15.83

5.6

6.5

25.04

24.91

mmol/l

0.12

127

457

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

307

1489

1.68

15.77

3.4

3.6

6.98

14.71

nmol/l

0.82

298

1448

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

223

986

1.84

15.77

1.4

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

418

2194

1.55

15.56

1.3

1.5

17.60

13.84

u/ml

—

(4062490) Immunoglobulin typing, IgG

252

1169

1.75

15.22

1.5

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

183

2708

0.54

15.19

1.2

1.49

1.50

g/l

0.24

183

2708

(3024139) IgG subclass 3 [Mass/volume] in Serum

255

1193

1.74

14.96

1.5

1.4

0.42

0.45

g/l

0.33

179

847

(3028192) IgG subclass 2 [Mass/volume] in Serum

255

1194

1.74

14.92

1.5

1.4

2.84

2.97

g/l

0.51

177

850

(3027135) IgG subclass 1 [Mass/volume] in Serum

255

1194

1.74

14.92

1.5

1.4

6.79

6.93

g/l

0.22

180

844

(3000764) Benzodiazepines [Presence] in Urine

449

2417

1.51

14.91

3.3

1.9

—

(3023419) Bacteria identified in Sputum by Culture

372

1921

1.58

14.89

2.5

2.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

134

505

2.15

14.89

1.6

1.4

2030126.91

1057056.00

iu/ml

0.54

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1139

7181

1.30

14.87

2.1

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

256

2.66

14.87

1.1

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

405

2136

1.54

14.78

2.9

2.2

6101.15

5670.70

u/l

0.10

130

815

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

169

702

1.95

14.48

2.2

2.4

512.88

503.90

e6/l

0.08

131

586

(3045788) Cell count panel - Pleural fluid

349

1788

1.59

14.46

1.6

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

159

3.11

14.27

2.6

3.0

127.38

54.57

mg/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

112

399

2.28

14.27

2.9

2.8

28.47

29.20

umol/l

0.26

298

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14649

114538

1.16

14.26

6.2

6.1

2.38

2.54

mmol/l

88.92

13337

105610

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

452

2463

1.50

14.18

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

131

500

2.13

14.12

34.3

30.1

103.36

110.61

ug/l

0.94

116

417

(3001019) Free T4 and TSH panel - Serum or Plasma

257

3398

0.61

14.01

1.7

1.6

—

(1175426) CD3 cells/Lymphocytes in Blood

198

877

1.83

13.99

1.9

72.19

71.09

0.40

186

834

(44790048) Parainfluenza type 2 nucleic acid detection

340

1747

1.58

13.94

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

340

1747

1.58

13.94

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

340

1747

1.58

13.94

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

170

719

1.92

13.85

2.2

15.04

31.46

umol/l

1.34

(3028300) Cannabinoids [Presence] in Urine

446

2438

1.49

13.79

3.5

1.9

—

(3027008) Opiates [Presence] in Urine

445

2432

1.49

13.78

3.3

1.9

—

(44806118) Parainfluenza type 4 nucleic acid detection

339

1747

1.58

13.73

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

363

1905

1.55

13.59

1.1

—

(3012565) Volume of 24 hour Urine

151

619

1.98

13.47

2.4

2.3

1888.49

1941.75

0.24

126

546

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

194

867

1.82

13.34

1.4

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

122

465

2.13

13.23

46.9

36.8

7.06

7.28

ug/l

0.59

108

408

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

102

361

2.29

13.23

1.3

1.2

39.70

20.73

—

(3023420) DNA double strand Ab [Units/volume] in Serum

739

4456

1.35

13.19

1.7

6.55

7.45

iu/ml

0.39

161

1076

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

376

2005

1.53

13.11

1.4

1.2

284.86

272.19

u/ml

0.37

241

1263

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

649

3843

1.38

12.99

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

196

892

1.78

12.72

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

578

3374

1.40

12.61

1.7

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

245

2.55

12.59

1.8

1.7

77.67

121.38

ug/l

4.41

206

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.76

12.57

1.1

—

(3027944) Amphetamines [Presence] in Urine

431

2388

1.47

12.51

3.1

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

114

433

2.13

12.50

2.5

2.7

0.61

mmol/l

0.30

114

433

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

165

716

1.87

12.49

2.3

2.5

224.21

234.36

e6/l

0.26

139

633

(3002079) Sodium [Moles/time] in 24 hour Urine

119

460

2.10

12.48

1.2

1.3

170.29

170.32

mmol/24h

0.00

119

460

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

160

688

1.89

12.46

1.1

1.88

10.39

nmol/l

2.49

148

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

278

1403

1.61

12.34

1.4

1.7

—

(3017704) Immunofixation for Urine

176

784

1.82

12.28

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

464

2618

1.44

12.26

1.5

1.3

35.72

37.49

u/l

0.13

408

2276

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

145

3.02

12.09

5.5

6.4

49.33

60.78

ug/min

0.51

121

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

414

2295

1.47

12.00

1.6

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

129

3.14

11.96

3.8

2.4

0.20

0.44

u/field

2.08

129

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

157

681

1.87

11.92

1.2

111.78

100.05

u/l

0.62

136

569

(3017817) Protein [Mass] in Urine collected for unspecified duration

262

1317

1.62

11.84

2.3

2.5

1245.72

973.86

1.10

256

1302

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13675

106794

1.13

11.83

4.6

4.5

1.31

1.29

mmol/l

2.60

12253

97050

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

549

3217

1.39

11.74

1.5

1.9

13.66

12.04

mg/l

1.10

511

3014

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

633

3804

1.36

11.59

1.6

22.14

22.70

u/ml

0.04

840

(3022493) Free Hemoglobin [Mass/volume] in Plasma

141

597

1.92

11.54

1.2

4.6

72.98

476.84

mg/l

0.51

100

422

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

261

2.42

11.52

2.6

2.5

6.98

7.90

mmol/l

1.26

155

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

260

1315

1.61

11.48

2.8

1.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

268

1370

1.59

11.32

1.3

13.29

14.02

u/l

0.25

248

1271

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

222

1085

1.66

11.23

1.8

1.6

28.05

27.20

u/ml

0.10

220

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

251

1266

1.61

11.22

1.4

13.77

13.25

u/l

0.59

240

1220

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

260

1323

1.60

11.20

1.5

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

531

3122

1.39

11.15

1.2

140.00

109.32

titre

0.32

294

(3000093) Morphology [Interpretation] in Blood Narrative

278

1440

1.57

11.11

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

654

3977

1.34

11.09

1.2

0.37

0.90

u/ml

2.38

352

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

296

2.30

11.09

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

372

2053

1.47

11.07

1.6

1.4

160.56

150.68

au/ml

0.97

128

605

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1142

7473

1.25

11.04

2.4

22.46

22.47

au/ml

0.00

671

(3021387) Prolactin [Units/volume] in Serum or Plasma

468

2698

1.41

11.03

1.8

357.63

280.43

mu/l

2.35

430

2465

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

407

2289

1.45

10.99

1.6

1.4

15.04

20.51

u/ml

0.37

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

288

2.31

10.91

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

766

4777

1.31

10.90

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.19

10.83

1.4

1.1

1.38

1.05

u/field

0.61

(3005532) Lymphocytes/Leukocytes in Pleural fluid

137

588

1.89

10.80

1.4

1.5

63.96

63.83

0.01

110

483

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

293

1548

1.54

10.75

1.3

0.64

2.56

nmol/l

0.84

281

1497

(3051387) C reactive protein [Mass/volume] in Capillary blood

480

2793

1.40

10.74

4.9

3.4

30.81

29.54

mg/l

0.32

370

1958

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

176

819

1.74

10.68

1.8

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1050

6834

1.26

10.64

1.3

56.85

54.80

au/ml

0.08

468

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

167

768

1.76

10.56

3.9

3.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

158

715

1.79

10.54

1.5

1.9

—

(3036603) Volume of Urine

201

974

1.68

10.54

1.5

1.6

2048.53

1901.83

1.29

196

944

(3009214) Lutropin [Units/volume] in Serum or Plasma

476

2775

1.40

10.54

1.4

10.48

9.09

u/l

1.31

374

2193

(3010503) CD19 cells [#/volume] in Blood

160

728

1.78

10.49

2.2

2.4

241.71

406.83

e6/l

0.45

149

701

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

269

1403

1.56

10.47

1.3

1.51

1.44

nmol/l

0.39

237

1275

(3000475) Leukocytes [#/volume] in Synovial fluid

567

3406

1.36

10.44

1.6

21062.81

14413.13

e6/l

1.26

401

2425

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

150

671

1.81

10.40

1.5

1.6

7.66

7.25

u/l

0.12

122

524

(3052592) Norovirus Ag [Presence] in Stool

249

2.37

10.39

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

334

1828

1.49

10.39

1.8

4.53

4.81

mmol/24h

0.77

293

1598

(3016650) Hepatitis A virus Ab [Presence] in Serum

339

1865

1.48

10.28

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

296

1584

1.52

10.26

1.3

0.40

0.26

nmol/l

0.47

134

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

328

2.17

10.21

1.2

14.85

13.90

pmol/l

0.11

122

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14310

112359

1.13

10.21

5.5

5.3

4.19

4.40

mmol/l

105.50

13059

104018

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

148

664

1.81

10.18

1.3

33.40

28.36

u/l

0.51

129

546

(3048929) Epstein Barr virus Ab [Presence] in Serum

494

2919

1.38

10.11

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

307

1663

1.50

10.06

1.5

1.4

71.47

63.93

mu/l

0.23

267

1488

(3006571) Granulocytes/Leukocytes in Synovial fluid

302

1631

1.50

10.04

1.6

1.5

60.69

61.17

0.07

202

1029

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

305

2.20

9.98

2.2

2.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

115

479

1.95

9.94

1.2

1.1

398.35

470.71

ng/l

0.07

142

(3003329) Lymphocytes/Leukocytes in Synovial fluid

240

1240

1.57

9.77

1.7

1.5

23.98

28.70

1.44

157

771

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

724

7457

0.78

9.76

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

216

1089

1.61

9.74

1.3

1.2

—

37.86

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

253

1326

1.55

9.68

1.3

—

nmol/l

—

(3034770) Mitochondria Ab [Titer] in Serum

517

3101

1.36

9.65

1.2

609.00

940.84

titre

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

190

932

1.65

9.56

1.9

1.7

422.92

343.67

mu/l

0.82

154

721

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

223

1139

1.59

9.54

1.2

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2668

19101

1.15

9.47

1.3

33.36

37.87

iu/ml

0.74

825

5699

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

330

1837

1.46

9.47

2.4

2.7

925.15

744.48

u/ml

0.11

323

1812

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

259

1372

1.53

9.45

1.3

0.19

0.21

nmol/l

0.91

205

1126

(3029634) Reagin Ab [Titer] in Serum by VDRL

257

1361

1.53

9.40

1.8

2.2

0.20

3.54

titre

—

(3005322) IgE [Units/volume] in Serum or Plasma

984

6451

1.25

9.38

1.4

1.3

281.08

292.53

u/ml

0.10

911

6003

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

178

865

1.67

9.30

1.2

93.57

105.85

pmol/l

2.22

178

865

(3000060) B lymphocytes [#/volume] in Blood

242

2.31

9.28

2.0

0.89

2.33

e9/l

0.52

120

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

143

654

1.77

9.28

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

342

2.08

9.23

1.2

1.1

—

(3035880) pH of Pleural fluid

194

968

1.63

9.15

1.3

7.37

7.39

0.40

133

687

(3034988) Calcium [Moles/volume] in Capillary blood

214

2.38

9.10

2.3

1.7

1.17

1.18

mmol/l

0.70

208

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

245

1297

1.53

8.99

1.2

1.1

—

9.60

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

446

2646

1.37

8.95

1.6

1.8

3.38

7.05

iu/l

0.83

154

994

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

158

2.61

8.92

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

788

5066

1.27

8.91

1.1

1.84

6.79

u/ml

0.60

(3017315) Amylase [Enzymatic activity/volume] in Urine

143

663

1.75

8.88

1.4

1.2

241.32

424.85

u/l

1.37

133

615

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

306

1703

1.46

8.83

1.8

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

143

665

1.74

8.79

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

299

1660

1.46

8.74

2.0

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

249

2.24

8.72

1.3

1.4

1.17

mmol/l

0.07

249

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

271

1476

1.49

8.72

4.0

3.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

157

756

1.68

8.53

1.3

1.2

80.50

84.36

—

(3007463) Buprenorphine [Presence] in Urine

7.35

8.51

2.4

9.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1402

9619

1.19

8.49

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

113

496

1.85

8.42

2.7

2.3

51.38

53.70

umol/l

0.31

425

(4015189) Microbial culture of sputum

361

2.00

8.37

2.0

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

674

4285

1.28

8.36

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14169

111557

1.11

8.24

5.4

5.2

1.33

1.39

mmol/l

64.20

12843

102449

(3001893) Eosinophils/Leukocytes in Pleural fluid

117

525

1.81

8.15

1.4

1.5

3.09

2.70

0.22

439

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

269

1485

1.47

8.13

1.2

3.80

6.13

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

433

2600

1.35

8.10

1.5

1.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

243

2.20

7.99

1.5

9.65

10.55

0.10

118

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

154

753

1.66

7.93

1.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

4513

39393

0.90

7.89

3.9

3.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

333

1925

1.41

7.87

1.1

—

(3006245) CD3-CD19+ cells/cells in Blood

381

1.94

7.86

2.2

2.0

9.40

10.61

0.35

349

(3036525) Urea [Moles/time] in 24 hour Urine

3.22

7.83

4.2

3.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

150

2.54

7.80

1.3

1.2

86.46

105.24

ug/l

0.49

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

278

1559

1.45

7.77

1.4

1.3

275.92

352.55

pmol/l

0.56

232

1266

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.25

7.77

1.1

1.2

2.90

1.04

u/field

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11943

93348

1.10

7.72

40.9

23.0

330.84

332.44

g/l

63.14

11863

92702

(3008116) Ketones [Moles/volume] in Urine by Test strip

284

2.08

7.71

1.7

1.4

0.32

0.28

mmol/l

0.09

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

153

753

1.65

7.70

1.3

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

231

1251

1.50

7.70

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

137

656

1.69

7.65

1.1

36.88

24.91

u/l

0.92

119

581

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

151

742

1.65

7.65

2.0

2.1

16.81

16.65

nmol/l

0.08

134

700

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

138

665

1.68

7.54

1.1

102.75

85.57

u/l

0.90

120

593

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

222

1199

1.50

7.51

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

222

1199

1.50

7.51

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

222

1199

1.50

7.51

1.4

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

118

547

1.75

7.41

1.2

1.1

—

1.24

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

495

3076

1.31

7.36

1.3

1.2

41.71

33.71

u/ml

0.17

161

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

243

1344

1.47

7.32

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

160

2.43

7.30

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

119

556

1.73

7.28

1.9

2.0

39.05

39.87

g/l

0.69

119

556

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

498

3113

1.30

7.10

2.7

3.5

803.35

1363.15

u/ml

0.51

447

2844

(3016330) Potassium [Moles/time] in 24 hour Urine

138

2.52

7.09

1.2

1.3

—

81.79

—

(3017509) Phencyclidine [Presence] in Urine

3.34

6.98

2.0

1.5

—

(3016228) CD19 cells/cells in Blood

106

486

1.77

6.94

1.9

8.93

7.88

0.33

472

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

136

670

1.65

6.87

1.5

6.72

6.42

u/l

0.14

108

573

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

406

1.84

6.83

1.7

1.9

1.95

1.65

ratio

0.90

392

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

321

1.94

6.79

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

171

2.32

6.78

2.4

3.8

41.21

40.67

umol/l

0.05

138

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2111

15208

1.14

6.74

5.0

5.2

32.92

32.48

0.99

1440

10052

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

181

963

1.52

6.63

1.1

1.0

710.88

729.73

ng/l

0.22

130

649

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

139

697

1.62

6.57

1.4

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

181

966

1.52

6.54

1.1

1.0

41.05

41.04

ng/l

0.00

129

661

(3006270) Folate [Moles/volume] in Blood

192

1038

1.50

6.53

1.3

1.2

298.74

340.36

nmol/l

2.03

151

836

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2429

17689

1.13

6.52

1.3

11.41

12.51

u/ml

0.18

816

6601

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.69

6.52

1.6

1.7

2.89

0.70

mg/l

0.97

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.69

6.52

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

180

962

1.52

6.47

1.1

1.0

345.71

327.99

ng/l

0.18

132

666

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

135

676

1.62

6.43

2.0

2.2

64.08

151.73

ug/min

1.38

167

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

171

2.27

6.36

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

141

2.41

6.34

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

537

3443

1.27

6.33

3.5

3.7

40.99

80.79

u/ml

5.11

519

3305

(3036670) Protein [Mass/volume] in Synovial fluid

423

1.78

6.30

1.2

1.3

38.51

41.07

g/l

1.14

215

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

127

630

1.63

6.29

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

175

936

1.52

6.28

1.3

604.12

504.83

titre

0.12

(3013139) Helicobacter pylori Ag [Presence] in Stool

1065

7330

1.18

6.27

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

215

1200

1.45

6.26

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

462

2912

1.29

6.24

1.3

7.27

6.73

u/ml

0.07

426

(3020717) Zinc [Moles/volume] in Serum or Plasma

112

539

1.68

6.23

1.8

1.5

17.67

21.81

umol/l

1.00

105

495

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

462

2913

1.29

6.23

1.3

1.2

11.35

5.19

u/ml

0.38

283

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

242

2.04

6.21

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

431

1.77

6.21

2.1

1.7

2.06

1.99

umol/l

0.32

397

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.73

6.17

1.2

12.76

14.13

pmol/l

0.13

(3042733) HLA Ab [Presence] in Serum

344

1.86

6.16

5.7

4.8

—

(3024869) Neuronal Ab [Presence] in Serum

232

2.06

6.15

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

278

1634

1.38

6.07

1.1

1.58

1.55

g/l

0.33

253

1486

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

136

693

1.59

6.06

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

136

693

1.59

6.06

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

693

1.59

6.06

1.5

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

135

691

1.58

5.92

1.5

1.8

—

(3034891) Synovial lining cells/cells in Synovial fluid

125

630

1.61

5.85

1.5

5.32

3.30

0.47

138

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.52

5.82

1.5

1.7

2.00

1.76

mg/l

0.08

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.52

5.82

1.5

1.7

5.40

3.96

mg/l

0.31

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.52

5.82

1.5

1.7

2.87

2.67

mg/l

0.05

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

169

913

1.50

5.82

1.3

40.71

79.52

titre

1.68

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

142

2.34

5.82

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

249

1.98

5.78

1.8

1.6

0.38

ug/l

0.03

161

(3023383) Lactate [Moles/volume] in Pleural fluid

111

545

1.65

5.76

1.3

3.97

3.67

mmol/l

0.31

102

502

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

148

780

1.54

5.73

2.5

2.4

0.67

0.61

e9/l

0.68

134

742

(3014891) Appearance of Pleural fluid

239

2.00

5.71

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

174

950

1.48

5.70

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

130

667

1.58

5.66

3.3

3.5

1.40

1.28

0.28

130

667

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.33

5.66

1.5

1.2

1.17

1.00

u/field

0.30

(40757373) Influenza virus identified in Isolate

268

1.93

5.65

1.4

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

548

3576

1.25

5.60

1.7

1.5

13.31

5.30

iu/ml

0.38

130

727

(3020911) Cortisol [Moles/time] in 24 hour Urine

344

1.81

5.58

1.2

1.5

306.71

245.70

nmol/24h

0.17

344

(3034274) Bile acid [Moles/volume] in Serum --fasting

156

838

1.51

5.54

2.1

1.9

9.58

8.83

umol/l

0.16

119

608

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

211

1203

1.42

5.54

1.2

36.75

42.20

u/ml

0.11

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

402

2531

1.29

5.53

1.3

1.2

3.13

4.24

u/ml

0.34

177

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

248

1.96

5.50

1.1

1.2

227.81

254.92

pmol/l

0.36

184

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

312

1900

1.33

5.47

1.1

34.27

628.57

iu/ml

0.95

359

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.59

5.45

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

173

2.15

5.42

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

140

739

1.54

5.41

1.4

1.3

1.67

1.90

u/ml

0.13

439

(3020961) Endomysium IgA Ab [Titer] in Serum

669

4477

1.22

5.39

1.1

163.46

177.72

titre

0.05

123

(40759836) Histone Ab [Presence] in Serum by Immunoblot

153

830

1.49

5.22

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

299

1.84

5.21

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

448

2882

1.26

5.21

1.3

1.2

3.43

10.26

u/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2133

15617

1.12

5.20

11.6

7.6

—

(3028433) Virus identified in Specimen by Culture

376

1.74

5.20

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

168

931

1.46

5.16

3.8

2.6

37.35

32.32

mg/l

0.78

136

686

(3045142) Bone marrow Pathology biopsy report

276

1667

1.34

5.14

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

203

1167

1.41

5.12

1.6

1.8

4.76

4.24

mg/l

0.49

192

1121

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

173

966

1.45

5.11

1.5

1.3

24.14

24.32

u/l

0.02

138

795

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

313

1.81

5.10

2.7

3.0

1.95

1.84

ratio

0.18

285

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

155

849

1.48

5.06

1.1

286.70

286.26

mg/l

0.03

138

775

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

101

2.48

5.05

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

144

778

1.50

5.02

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

399

1.70

4.99

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

137

2.24

4.98

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

155

852

1.47

4.98

1.2

—

(3020491) Glucose [Moles/volume] in Blood

160

886

1.46

4.95

2.2

2.0

7.23

7.12

mmol/l

0.15

118

605

(3004616) Nuclear Ab [Presence] in Serum

236

1401

1.37

4.94

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

103

2.43

4.86

3.3

1.8

—

(3027874) Urate [Moles/volume] in Urine

3.20

4.85

1.2

1.1

1.61

1.81

mmol/l

0.26

(3000919) Neutrophils/Leukocytes in Pleural fluid

490

1.62

4.81

1.4

24.16

20.51

0.59

434

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

171

2.08

4.81

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

361

1.73

4.81

1.2

1.3

136.02

129.00

nmol/l

0.12

263

(3047189) Immunofixation for 24 hour Urine

136

734

1.50

4.79

1.5

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.98

4.79

1.1

1.2

1.63

1.53

iu/ml

0.10

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

187

1074

1.41

4.78

2.3

2.4

33.63

27.60

iu/ml

0.29

126

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.82

4.77

1.3

1.1

34.11

139.91

u/l

0.56

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

162

909

1.44

4.70

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

114

596

1.55

4.66

1.7

2.2

98.39

96.06

0.29

109

568

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

199

1161

1.39

4.65

1.2

1.1

2.63

1.81

iu/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

865

6008

1.17

4.65

1.2

128.72

126.32

u/ml

0.05

304

2103

(3018333) Ribosomal P Ab [Presence] in Serum

139

760

1.48

4.62

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

147

813

1.47

4.61

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.88

4.53

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

128

2.21

4.47

1.9

1.7

44.51

46.45

umol/l

0.17

128

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

146

812

1.46

4.46

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

107

558

1.55

4.44

1.2

1.3

218.53

291.92

ug/l

0.18

289

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

255

1566

1.32

4.32

1.3

1.2

5.80

3.62

u/ml

0.71

120

720

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

429

1.62

4.31

1.5

1.8

176.81

174.79

0.07

406

(3030313) Adrenal Ab [Titer] in Serum

2.96

4.29

1.1

—

19.00

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.47

4.25

1.7

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

502

1.56

4.19

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

132

2.15

4.17

2.3

1.8

1.32

1.43

mmol/l

0.08

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

492

1.56

4.10

1.7

8.63

9.96

nmol/l

0.07

409

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

383

2495

1.25

4.09

1.2

1.1

3.52

3.83

0.16

260

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.55

4.00

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

103

2.28

3.99

1.1

631.30

287.44

u/ml

—

(44786800) Granulocytes/Leukocytes in Body fluid

196

1.90

3.97

1.3

31.97

24.40

0.57

156

(3010144) Erythrocytes [#/volume] in Synovial fluid

214

1300

1.33

3.95

1.5

1.3

174284.60

144973.65

e6/l

0.21

166

840

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

332

2138

1.26

3.94

1.3

1.2

40.92

40.10

u/ml

0.03

204

(3027923) C peptide [Moles/volume] in Serum or Plasma

138

780

1.43

3.93

1.3

1.12

1.25

nmol/l

0.68

582

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.99

3.93

1.2

0.10

0.69

iu/ml

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

163

950

1.39

3.91

1.3

1.2

233.75

88.75

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

163

950

1.39

3.91

1.3

1.2

177.24

181.44

titre

0.02

160

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

110

2.21

3.85

1.9

1.7

—

(3006462) Nitrate [Presence] in Urine

103

552

1.51

3.84

3.8

3.2

—

(1002224) Polysomnography panel

441

4302

0.82

3.84

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

138

784

1.43

3.83

1.3

1.4

14.41

13.79

umol/l

0.42

127

730

(3006922) Hepatitis E virus Ab [Presence] in Serum

150

865

1.40

3.83

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

176

1.93

3.82

1.1

1.2

17.07

16.99

g/l

0.02

163

(3001964) Herpes simplex virus Ag [Presence] in Specimen

306

1.69

3.81

1.2

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

234

1.80

3.81

1.5

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

139

792

1.42

3.80

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

133

2.07

3.73

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.70

3.69

1.4

295.68

346.33

umol/24h

0.43

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.68

3.67

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

173

1.92

3.67

1.4

1.7

45.45

46.73

pmol/l

0.04

142

(4268621) Lupus anticoagulant assay

181

1087

1.35

3.64

2.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

456

1.54

3.61

3.1

20.40

24.44

mu/l

0.66

425

(4211845) Urine protein measurement

110

607

1.47

3.59

3.8

3.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

275

1.71

3.58

1.1

1.2

88.41

83.81

0.73

150

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

509

1.51

3.57

1.1

1531.11

1513.75

miu/ml

0.05

509

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

252

1.73

3.53

1.2

52.05

77.23

mg/l

0.16

190

(3039162) Centromere protein B Ab [Units/volume] in Serum

208

1282

1.31

3.52

1.3

1.2

60.64

49.84

u/ml

0.22

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

377

1.59

3.48

1.4

1.7

18.92

268.48

pmol/l

0.84

(3020650) Glucose [Presence] in Urine

377

1.59

3.48

2.5

1.5

0.08

0.03

estimate

0.39

377

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

8.08

3.48

1.1

1.0

2.00

1.14

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

327

1.63

3.47

1.1

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

6.47

3.47

2.1

2.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

110

2.13

3.46

2.3

2.1

0.65

0.66

ug/l

0.04

110

(3050129) First trimester maternal screen panel - Serum or Plasma

134

1495

0.72

3.44

1.5

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

178

1079

1.34

3.39

3.3

2.9

41.89

51.05

mg/l

0.38

147

776

(3026051) Granulocytes/Leukocytes in Pleural fluid

374

1.58

3.37

1.4

23.62

22.71

0.09

322

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

129

745

1.40

3.33

1.1

1.0

—

0.55

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.70

3.32

1.6

1.4

21.76

24.05

nmol/l

0.08

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

250

1593

1.27

3.31

1.3

1.2

3.32

4.14

u/ml

0.33

576

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

332

1.61

3.29

1.0

1.1

—

(40768443) Skin Pathology biopsy report

792

5621

1.15

3.29

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

129

2.01

3.28

1.5

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

102

2.14

3.27

1.0

1.1

9.30

11.79

u/l

0.35

102

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

1.87

3.22

1.2

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.82

3.18

1.1

1.0

382.71

112.48

pmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

142

1.94

3.18

4.2

3.2

1.33

1.27

mg/l

0.09

108

(43055514) Macroprolactin [Presence] in Serum or Plasma

171

1.85

3.16

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.59

3.15

1.3

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.26

3.14

1.1

2.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

183

1128

1.31

3.14

1.1

96.14

97.06

0.16

167

1058

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

137

1.95

3.14

1.2

1.1

0.08

0.35

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

1.97

3.06

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.55

3.03

2.9

1.1

1.62

2.13

g/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

516

1.46

3.02

1.6

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

194

2010

0.78

3.01

1.5

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.04

3.01

1.4

1.2

1.50

1.95

mmol/24h

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

271

1.64

3.01

1.2

1.3

93.39

80.31

2.26

151

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

510

1.46

3.00

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

511

1.46

2.97

1.6

2.0

—

(3024471) HLA-A [Type]

342

1.56

2.95

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

336

3270

0.83

2.95

1.6

1.7

5.25

4.87

mg/l

0.16

275

2435

(3044007) Cell count panel - Peritoneal fluid

460

1.48

2.92

1.7

2.0

—

(4146454) Self-monitoring of blood glucose

245

1586

1.25

2.89

2.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

359

1.53

2.82

1.3

1.4

51.66

41.37

g/l

0.15

269

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

353

2386

1.20

2.76

1.1

9.92

7.69

eliau/ml

0.22

242

(3000285) Sodium [Moles/volume] in Blood

284

1.60

2.76

1.3

1.2

137.98

138.74

mmol/l

0.83

238

(3033923) Metanephrine [Moles/time] in 24 hour Urine

204

1.71

2.73

1.2

0.73

0.68

umol/24h

0.21

(3028679) Herpes simplex virus Ab [Presence] in Serum

502

1.44

2.69

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

268

1.60

2.66

5.6

6.0

8.86

8.61

mmol/l

0.28

268

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

391

1.49

2.64

1.2

1.1

—

(3012898) Urea [Moles/volume] in Urine

129

1.88

2.63

1.4

1.2

122.13

173.23

mmol/l

2.41

109

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

101

2.00

2.61

1.4

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

232

1.64

2.60

1.3

1.2

50.00

140.79

titre

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.18

2.59

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

334

1.53

2.59

1.2

1.48

1.50

mmol/l

0.05

215

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

171

1.75

2.59

1.2

1.1

18.73

20.02

u/l

0.20

108

(3024263) Appearance of Synovial fluid

113

670

1.37

2.58

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

403

2777

1.18

2.56

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

510

0.60

2.55

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.57

2.55

1.8

1.4

294.84

505.35

nmol/l

1.39

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.12

2.54

2.9

3.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

388

1.48

2.54

1.2

3.89

4.25

umol/l

0.35

340

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

223

1453

1.24

2.54

1.1

117.32

113.96

0.83

202

1310

(3036180) Methadone [Presence] in Urine

4.72

2.53

1.4

1.9

—

(40768793) Breast Pathology biopsy report

160

1655

0.78

2.52

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

462

1.44

2.52

2.3

1.9

10122.82

14504.56

e6/l

0.28

242

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.04

2.51

1.8

1.9

172.99

257.38

ug/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1019

0.72

2.50

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

149

1.79

2.50

1.2

60.91

64.97

ug/l

0.50

149

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

517

3647

1.15

2.44

2.4

2.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

230

1.62

2.44

1.2

1.3

64.36

208.55

u/l

0.54

166

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

2.44

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

433

3016

1.16

2.43

2.2

2.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

104

1.94

2.42

1.4

1.3

0.12

0.19

nmol/l

1.38

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

184

1180

1.26

2.42

1.5

1.6

—

(4195642) Thrombophilia screening test

220

1441

1.24

2.41

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

231

1.61

2.40

1.2

1.3

52.93

69.68

mu/l

0.37

172

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

362

1.48

2.35

1.3

0.31

0.30

g/l

0.12

292

(3024932) HLA-DR beta [Type]

336

1.49

2.34

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

229

1512

1.23

2.34

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

310

1.51

2.33

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

573

1.37

2.31

1.4

1.5

7.81

9.58

ug/l

0.79

520

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.96

2.29

1.6

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

325

1.49

2.28

1.6

1.4

14.43

15.96

pmol/l

1.17

265

(3001218) Citrate [Mass/time] in 24 hour Urine

4.85

2.27

1.0

1.4

340.33

470.60

mg/24h

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.99

2.26

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

186

1.65

2.21

1.2

1.3

352.11

528.07

ng/l

0.16

132

(40768441) Liver Pathology biopsy report

143

902

1.28

2.19

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

335

1.47

2.18

1.3

112.96

112.27

0.07

299

(3001556) Androgen free Index in Serum or Plasma

2.36

2.17

1.3

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.70

2.16

1.2

—

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1058

9309

0.91

2.14

1.6

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

431

1.41

2.12

1.2

0.25

0.14

g/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.08

2.11

1.2

1.1

0.12

0.03

u/ml

0.50

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.60

2.08

1.2

84.57

78.82

0.23

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

967

0.74

2.08

1.1

1.0

0.11

0.25

u/ml

1.37

335

(4133840) Spirometry

273

1.51

2.07

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

203

1.59

2.05

1.2

73.00

68.92

0.23

(3042010) Triglyceride [Moles/volume] in Pleural fluid

262

1.51

2.01

1.2

2.05

1.28

mmol/l

0.33

177

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.54

1.98

3.4

4.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

929

6880

1.10

1.96

1.8

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

544

1.34

1.91

2.3

2.0

6922.81

2906.63

e6/l

0.28

374

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

114

0.35

1.90

4.0

6.3

7.00

8.16

—

114

(40761995) Spermatozoa Progressive [#/volume] in Semen

115

0.35

1.90

2.0

3.1

38.40

43.75

—

115

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

319

1.45

1.89

2.2

2.4

2769.74

280.26

ug/l

0.70

319

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.94

1.89

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

311

0.57

1.88

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.87

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

411

2917

1.14

1.86

1.5

1.4

24.77

25.56

iu/l

0.18

346

2461

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

1.83

1.86

2.0

2.1

14.38

17.81

0.20

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

675

1.29

1.83

1.5

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.14

1.80

1.4

1.2

170.00

131.82

nmol/l

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

123

1.71

1.76

2.3

2.2

53.70

64.54

0.80

(3001729) Color of Synovial fluid

105

1.77

1.76

1.9

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

148

967

1.24

1.76

1.2

1.3

9.88

9.24

mmol/l

0.88

138

899

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

238

1.50

1.75

1.2

—

(3034426) Prothrombin time (PT)

325

1.42

1.74

1.1

1.2

28.02

28.55

0.34

325

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

109

1120

0.79

1.74

1.7

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

1041

1.23

1.74

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

204

1379

1.20

1.73

1.5

186.49

167.17

pmol/l

0.14

198

1337

(3026692) Albumin [Mass/volume] in Peritoneal fluid

421

1.36

1.73

1.9

1.3

14.36

12.87

g/l

0.71

308

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

130

1.68

1.73

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

864

0.76

1.73

1.5

60.86

59.52

ug/l

0.11

864

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

513

1.32

1.70

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.94

1.69

11.4

12.1

238.58

234.17

e6/l

0.02

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

113

1.72

1.67

1.3

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

368

0.64

1.65

1.5

1.6

2773.33

3436.52

titre

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

173

1679

0.83

1.63

1.2

1.1

1.36

1.79

u/ml

0.50

100

903

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

920

0.77

1.63

6.2

3.2

13.45

13.23

1.46

908

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

175

1695

0.83

1.62

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

144

1421

0.82

1.62

1.1

4.44

3.78

u/ml

0.17

729

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.80

1.61

1.1

1.3

0.05

0.07

g/l

1.87

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

462

1.33

1.60

1.3

1.8

132386.60

15623.89

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

317

2238

1.15

1.60

1.3

219.66

220.40

miu/ml

0.01

863

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

155

1030

1.22

1.60

1.7

1.5

0.28

0.33

nmol/l

0.54

116

782

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

388

1.36

1.55

5.4

6.2

69.71

70.17

0.04

308

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

116

750

1.25

1.55

3.0

2.6

40.33

36.87

1.09

416

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.96

1.55

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

141

1.61

1.54

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

142

940

1.22

1.53

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

410

1.34

1.53

13.4

7.6

5.77

5.97

kpa

1.09

355

(21494434) Karyotype in Bone marrow

201

1376

1.18

1.52

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

113

1135

0.80

1.52

1.1

2.77

2.89

u/ml

0.04

570

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.82

1.52

1.1

1.3

3585.63

2292.45

ng/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

399

0.67

1.52

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

224

1550

1.17

1.50

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

3.37

1.49

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.93

1.49

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

131

1291

0.82

1.48

1.2

1.1

0.95

1.24

u/ml

0.31

651

(46235168) Fasting glucose [Moles/volume] in Blood

130

1.62

1.48

2.0

2.8

7.64

7.45

mmol/l

0.15

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.85

1.42

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

132

1.59

1.41

15.6

10.1

0.28

0.25

0.37

132

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.46

1.39

1.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

178

1.50

1.38

1.8

1.2

33.11

49.81

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

969

0.80

1.38

1.5

1.3

147.43

177.43

pmol/l

1.30

969

(40758047) Lysozyme [Mass/volume] in Pleural fluid

165

1.52

1.38

1.4

1.2

9.72

8.61

mg/l

0.25

153

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

172

1.50

1.37

1.4

1.2

40.05

44.19

mg/l

0.22

143

(44806420) Estimation of glomerular filtration rate

148

998

1.20

1.36

2.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.95

1.34

1.2

1.1

297.23

252.40

nmol/l

0.23

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

163

1111

1.19

1.34

1.1

2.63

3.94

eliau/ml

0.55

449

(3008401) Mugwort IgE Ab [Units/volume] in Serum

143

1372

0.84

1.26

1.2

1.1

0.87

0.89

u/ml

0.03

596

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.65

1.26

4.0

4.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

203

1.43

1.24

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

355

1.32

1.23

14.1

7.6

6.18

5.34

kpa

1.27

355

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

138

1.52

1.20

1.1

21.50

18.50

iu/ml

0.11

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.80

1.17

1.3

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

120

810

1.20

1.14

5.0

5.8

152.27

71.74

u/ml

0.26

268

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1863

14434

1.05

1.14

1.6

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.53

1.13

1.2

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.36

1.13

1.3

1.1

0.03

0.05

u/ml

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.26

1.10

1.0

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

195

1.41

1.10

1.4

1.3

65.22

70.83

0.43

169

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.78

1.07

1.0

9.57

8.08

0.60

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.78

1.07

1.0

1.1

21.31

20.73

0.21

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.78

1.07

1.0

1.1

36.06

36.82

0.15

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.83

1.07

1.1

1.5

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.18

1.07

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

400

1.27

1.06

1.6

1.3

63.37

58.90

0.48

337

(3007916) DNA double strand Ab [Titer] in Serum

110

1.54

1.05

1.1

1.2

—

72.74

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

575

1.22

1.04

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

150

1.46

1.04

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

150

1.46

1.04

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

150

1.46

1.04

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

216

1542

1.13

1.03

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.92

1.02

1.1

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.92

1.02

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.45

1.01

1.0

5.74

6.41

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.02

1.00

1.4

1.6

26.86

36.13

umol/24h

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.25

0.99

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

132

1239

0.86

0.96

1.2

7.93

7.62

mmol/l

0.57

111

1045

(4094501) Cardiovascular stress test using bicycle ergometer

381

3347

0.92

0.90

1.1

—

(3024316) Viscosity of Plasma

1.64

0.90

1.6

2.0

1.59

1.85

mpas

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.89

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

184

1317

1.13

0.88

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

219

1.33

0.86

1.3

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

1.75

0.82

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

1065

0.86

0.82

1.1

3.03

3.18

u/ml

0.06

480

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

183

1318

1.12

0.81

1.1

3.27

3.04

0.04

162

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.87

0.80

3.2

4.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

301

1.26

0.79

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.57

0.79

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

331

1.25

0.78

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

339

1.24

0.77

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.72

0.76

1.1

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

106

1.45

0.76

1.3

2.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

364

0.78

0.75

1.2

1.0

0.36

1.31

u/ml

0.50

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

199

1449

1.11

0.75

1.1

19.31

18.65

au/ml

0.03

300

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

2.13

0.75

1.4

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

370

1.22

0.74

1.1

4.42

4.52

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1445

12105

0.96

0.73

1.6

—

6.10

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

100

1.46

0.73

1.1

1.2

1.74

1.84

umol/24h

0.10

100

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.65

0.73

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.77

0.71

10.0

8.4

—

(3016135) IgD [Mass/volume] in Serum

1.92

0.70

1.2

1.0

80.62

34.16

mg/l

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.92

0.70

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

260

2288

0.92

0.70

1.6

962.76

1004.85

mu/l

0.31

195

1910

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.55

0.69

1.0

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

500

1.18

0.68

1.0

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.66

0.68

2.6

1.2

0.50

0.35

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

432

3273

1.07

0.68

2.0

1.9

186.35

200.06

pmol/l

2.00

397

3057

(3012494) Peanut IgE Ab [Units/volume] in Serum

194

1.29

0.65

1.2

1.1

0.27

1.12

u/ml

1.04

(3037692) Legionella sp identified in Specimen by Organism specific culture

495

1.18

0.65

1.2

1.5

—

(3018291) Platelet Ab [Presence] in Serum

1.76

0.64

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.62

0.63

49.6

9.8

108.20

106.84

g/l

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

118

1.37

0.62

1.1

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.62

0.62

5.4

6.2

624.38

429.10

umol/l

—

(3033099) Centromere Ab [Titer] in Serum

276

1.23

0.61

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.44

0.61

1.9

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

128

926

1.12

0.59

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

133

965

1.11

0.58

2.1

2.2

4.33

3.49

ug/l

0.33

122

892

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

162

1.30

0.58

1.1

1.3

376200.93

136505.24

nmol/l

0.26

137

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.73

0.58

1.2

1.1

28.13

35.25

mg/24h

—

(3008898) HLA-B27 [Presence]

377

2865

1.06

0.57

1.1

—

(40765096) Chromosome analysis panel by Banding

443

1.17

0.56

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.55

0.56

1.1

1.3

—

(3025577) Chromium [Mass/volume] in Blood

128

934

1.11

0.52

2.2

2.73

2.04

ug/l

0.52

104

777

(3014599) Egg white IgE Ab [Units/volume] in Serum

415

0.84

0.52

1.2

1.0

4.90

0.95

u/ml

0.41

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.39

0.52

1.1

100.27

104.83

titre

0.08

(3036048) Francisella tularensis Ab [Titer] in Serum

282

0.80

0.51

1.1

1.2

—

467.69

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

305

1.19

0.51

1.8

1.5

10.48

9.53

ug/l

0.68

305

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

569

1.14

0.51

6.4

7.4

63.89

215.66

ug/l

1.00

375

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.45

0.50

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

166

1.27

0.50

1.5

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.36

0.49

4.7

5.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5844

47775

0.98

0.49

2.0

1.9

1.37

1.33

mmol/l

2.91

4776

39321

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

397

1.16

0.48

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.46

0.48

6.8

3.9

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.43

0.47

2.7

1.4

—

(3019174) dRVVT (LA screen)

1.38

0.47

1.1

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.45

0.46

1.3

1.1

—

(4281824) Cell count and differential, peritoneal fluid

130

958

1.10

0.46

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

606

0.88

0.45

5.5

46.00

1690.23

u/ml

0.72

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

280

1.18

0.45

2.3

2.1

9.65

8.95

mg/l

0.31

232

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

133

0.73

0.45

1.2

1.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

184

1.23

0.44

2.0

1.8

2.14

2.17

ug/l

0.01

100

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

319

0.84

0.43

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

136

1009

1.09

0.43

1.6

1.5

—

(4038314) Semen analysis, post vasectomy

1.62

0.43

1.6

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

274

1.18

0.43

1.8

2.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.41

0.42

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.41

0.42

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

2886.46

—

(3005033) Fetal Nuchal fold Thickness US

134

997

1.09

0.41

1.6

1.5

1.15

1.27

2.08

706

(3046861) Legionella sp Ag [Presence] in Urine

1.31

0.40

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.40

0.0

1.3

—

(44813793) Dust mix specific IgE antibody measurement

650

1.11

0.40

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

411

0.86

0.40

1.1

1.3

11.57

11.52

mm/h

0.01

411

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

129

0.75

0.38

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

1.29

0.38

1.1

0.01

0.88

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.37

0.36

2.8

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

656

1.10

0.35

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

138

1.23

0.35

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

180

0.81

0.34

1.2

1.1

98.89

66.20

u/ml

0.68

174

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

1.31

0.34

2.7

1.3

50.25

39.87

—

(44806071) Cardiolipin IgM antibody measurement

144

0.79

0.34

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

179

0.81

0.33

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

117

1.24

0.33

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

252

1.15

0.32

2.7

2.5

3.08

3.13

ug/l

0.05

(3029396) Erythrocyte agglutination [Presence] in Blood

147

1.21

0.32

2.5

2.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

421

1.11

0.31

1.2

1.0

0.37

1.94

u/ml

1.13

134

(3043238) Trisomy 21 risk [Likelihood] in Fetus

137

1037

1.07

0.30

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

384

1.12

0.30

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

384

1.12

0.30

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

384

1.12

0.30

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

384

1.12

0.30

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

158

1203

1.06

0.30

1.6

1.5

1.10

1.14

ratio

0.18

703

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

158

1205

1.06

0.29

1.6

1.5

0.86

0.95

ratio

3.33

705

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

158

1205

1.06

0.29

1.6

1.5

1.14

1.18

ratio

0.26

709

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

135

1.20

0.27

1.7

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.28

0.27

1.7

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

530

4163

1.03

0.26

2.0

1.8

45.91

44.34

nmol/l

0.64

506

4023

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

156

1194

1.06

0.26

1.6

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

265

1.13

0.26

1.4

28.96

35.23

nmol/l

0.81

233

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

151

1.18

0.26

1.0

27.34

35.65

iu/ml

0.44

151

(3044009) aPTT.lupus sensitive (LA screen)

1.25

0.26

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

350

1.11

0.26

1.4

1.3

43.00

33.63

0.93

236

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

274

1.12

0.25

1.1

700.00

991.80

titre

—

(4034850) Laboratory test

504

3963

1.03

0.24

14.7

11.1

—

(4212803) Bone marrow aspirate examination

146

0.83

0.24

1.1

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

570

1.08

0.24

1.2

—

(40758358) Immune stain study

1.35

0.23

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

291

1.11

0.23

6.4

7.2

9.68

10.39

1.56

291

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.24

0.23

1.0

2.8

1.80

42.14

pmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

123

1.18

0.23

1.8

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.19

0.21

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

6.66

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(40762887) Creatinine [Moles/volume] in Blood

102

1.19

0.20

1.8

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

279

0.90

0.20

3.0

3.6

8.79

7.79

mg/l

0.27

230

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

186

1.13

0.20

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.18

0.19

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.18

0.19

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.13

0.17

1.1

1.4

0.16

umol/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

532

1.06

0.17

1.1

34.24

20.26

u/ml

0.77

200

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

173

1.12

0.17

1.3

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

766

1.04

0.14

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

348

1.07

0.14

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.85

0.13

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

179

1405

1.03

0.13

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.19

0.13

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

278

1.08

0.13

1.7

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.14

0.12

1.1

6.33

6.06

mmol/l

0.57

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

227

0.93

0.11

1.1

1.0

4.04

10.06

u/ml

2.25

147

(40768795) Lymph node Pathology biopsy report

155

1221

1.03

0.10

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

140

1.10

0.10

1.4

1.3

7.06

6.76

mmol/l

0.06

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.12

0.10

1.0

0.01

0.31

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.04

0.09

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

577

1.04

0.09

1.2

1.1

1.09

1.07

ratio

0.34

462

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.11

0.07

1.4

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

104

1.09

0.05

3.4

4.6

119.96

39.76

mg/mmol

0.81

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

147

0.93

0.05

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

176

1405

1.01

0.04

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

611

1.02

0.03

1.0

8.23

9.65

iu/ml

0.28

152

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

195

1.04

0.02

2.0

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

615

0.99

0.02

1.2

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.08

0.02

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

161

1292

1.01

0.02

1.6

1.5

61.84

59.52

ug/l

0.25

128

1073

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

387

0.98

0.02

1.2

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

662

0.99

0.01

1.3

1.5

2.82

4.01

ug/l

1.36

576

(40758292) HTLV I+II Ab panel - Serum

208

0.97

0.01

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

261

1.02

0.01

1.2

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

464

1.01

0.00

2.2

2.1

19.02

512.04

ug/l

1.40

441

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.05

0.00

1.5

2.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

396

1.00

0.00

1.1

99.95

95.55

0.39

307

(3025130) Human papilloma virus identified in Specimen

105

845

1.00

0.00

1.6

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

379

1.00

0.00

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

159

1.02

0.00

2.0

1.6

0.51

0.49

e9/l

0.12

159

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

19.28

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.4

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3025481) Topiramate [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

31.57

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.99

-0.00

12.3

10.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.92

-0.00

1.6

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.93

-0.00

1.3

1.37

1.36

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint R18_RETEN_URINE and mortality.

Females

Parameter	HR [95% CI]	p-value
R18_RETEN_URINE	2.114 [1.91, 2.34]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.019

During the follow-up period (1.1.1998 — 31.12.2019), 8761 out of 23480 females with R18_RETEN_URINE died.

Males

Parameter	HR [95% CI]	p-value
R18_RETEN_URINE	1.954 [1.76, 2.17]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 37950 out of 77816 males with R18_RETEN_URINE died.

Mortality risk

Mortality risk for people of age

years, who have R18_RETEN_URINE.

N-year risk	Females	Males
1	0.165%	0.372%
5	1.217%	1.993%
10	2.776%	4.779%
15	5.002%	8.751%
20	8.499%	14.307%

Relationships between endpoints

↥

Index endpoint: R18_RETEN_URINE – Retention of urine

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Retention of urine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints